Professor Bruce Robinson

AM
Professor and Dean
Medicine, Northern Clinical School
Kolling Institute of Medical Research

Telephone +61 2 9926 7267 or 9351 6570
Fax +61 2 9926 8523 or 9351 3196

Website Related website
Related website

Map

Research interests

Professor Bruce Robinson was appointed Dean of Sydney Medical School in 2007. As Dean, he leads one of the largest medical schools in Australia and the most research-intensive faculty within the University of Sydney. Sydney Medical School has more than 3000 academic faculty members and teaches over 5000 students across undergraduate medical sciences, medicine, postgraduate professional courses and higher research degrees.

Professor Robinson is an Endocrinologist. His research has focused on identifying genetic changes which either predispose or directly cause endocrine tumours, and among other highlights has been the formation of an international consortium of families from around the world to study medullary thyroid carcinoma and phaeochromocytoma. He has been head of the Cancer Genetics Unit at the Kolling Institute of Medical research, Royal North Shore Hospital, since 1989. He continues to practice at Sydney’s Royal North Shore Hospital.

Professor Robinson has supervised 37 PhD students and has more than 250 research publications.

Since 2001, he has been Chairman of Hoc Mai Foundation, a major program in medical and health education and exchange with Vietnam. He is a Board Member of the Woolcock Institute, the ANZAC Research Institute and the Centenary Institute for Cancer Research. He is also Board Member of the Royal Flying Doctor Service (South-Eastern Division) and is Chair of RFDS Medical Advisory Committee.

PhD and master's project opportunities

Selected grants

2013

  • Establishment of a Preconception Cohort Study in VietNam to link with the Charles Perkins Centre Cohort study; Morris J, Baur L, Benn D, Glasson R, Robinson B, Simpson S, Dang D, Tran T, Smyth C; DVC International/IPDF Grant.

2012

  • Mitochondrial Dysfunction and Hypoxic Responses: Implications for Tumorigenesis; Dwight T, Clifton-Bligh R, Benn D, Robinson B; Pheo Para Alliance/Project grant.
  • The Australasian Succinate Dehydrogenase Consortium; Dwight T, Clifton-Bligh R, Benn D, Robinson B; Pheo Para Alliance/Project grant.
  • Data Linkage for NSW Bioresources using CHeReL; Baxter R, Robinson B, Boyle F, Clarke C, Marsh D; Cancer Institute New South Wales/Biobanking Stakeholder Network Funding.
  • SJ Atkinson Beq Otolarygology; Robinson B; SJ Atkinson Bequest/Bequest.
  • MatthewVernonDuncombeMelanoma; Robinson B; Matthew Vernon Duncombe Melanoma/Bequest.
  • Alan&BerylStephensArthritisDon; Robinson B; Alan & Beryl Stephens/Arthritis Donation.
  • Alan&BerylStephens Cancer Don; Robinson B; Alan & Beryl Stephens/Cancer Donation.

2011

  • Developing key research and exchange partnerships with Ecole Polytecnique Federale de Lausanne; Robinson B; DVC International/IPDF Grant.

2010

  • In-Vivo Multispectral Imaging FX System: small animal imaging for multi-modal molecular signal localisation in live animals; Marsh D, Baxter R, Ashton A, Howell V, Soon P, Little D, Robinson B; Cancer Institute New South Wales/Equipment Grant.
  • MicroRNA expression signatures and their functional significance in Medullary Thyroid Carcinoma; Robinson B, Messina M; Cancer Institute New South Wales/Research Innovation Grants.

2009

  • The role of IQGAP1 in actively migrating glioma cells and its regulation by MiR-124; McDonald K, Bennett M, Davey R, Robinson B; Cancer Council New South Wales/Research Project Grants.

2008

  • Cross-talk between PPARg and MAP kinase pathways in thyroid cancer; Clifton-Bligh R, Au A, Learoyd D, Robinson B; Cancer Council New South Wales/Research Project Grants.
  • Thyroid cancer - enhancing management and research outcomes; Learoyd D, Robinson B, Roach P, Delbridge L; Cancer Institute New South Wales/Infrastructure Grant.

2007

  • Oligodendrogliomas with LOH 1p/19q: identifying genes associated with therapeutic sensitivity; Robinson B, McDonald K; Cancer Institute New South Wales/Research Grant.
  • Confocal microscope for cancer research in the Northern Hub; Baxter R, Robinson B; Cancer Institute New South Wales/Infrastructure Grant.
  • Tumour bank officer in the Northern Hub; Smith R, Marsh D, Baxter R, Robinson B; Cancer Institute New South Wales/Infrastructure Grant.

2006

  • Alternative lengthening of Telomeres & outcome of Glioblastoma Multiforme; Robinson B; University of Sydney/Cancer Research Fund.
  • CDAMS Medical Schools Outcomes Database & Longitudinal tracking; Coats A, Robinson B; Commonwealth Department of Health and Ageing/Research Grant.
  • FAXSCalibur 4 -colour Flow Cytometer; Baxter R, Firth S, Marsh D, Schedlich L, Scott C, Martin J, Robinson B; Cancer Institute New South Wales/Research Grants Program - Category 2.

2005

  • Automated Precision Liquid Handling System; Benn D, Chen X, Chung L, Baxter R, Marsh D, Robinson B, Firth S; University of Sydney/Research Support.

2004

  • A randomised controlled trial of normoglycaemia versus conventional glycaemic control in Intensive Care Unit patients.; Robinson B, Norton R, Mitchell I, Myburgh J, Bellomo R, Finfer S; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Parathyroid tumorigenesis - a role for the newly identified putative tumour supressor HRPT2; Marsh D, Robinson B; National Health and Medical Research Council (NHMRC)/Project Grants.

2002

  • Novel fusion oncoproteins in follicular thyroid carcinoma; Robinson B; University of Sydney/Cancer Research Fund.

2001

  • The identification of novel genes involved in the intiation and development of thyroid neoplasia; Marsh D, Robinson B; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Autoimmune thyroid disease research collaborative agreement between The University of Sydney and Oxagen Ltd, et al.; Taylor J, Robinson B; Oxagen Ltd (UK)/Research Grants.

2000

  • Mechanisms of corticosteroid osteoporosis; Sambrook P, Mason R, Robinson B; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Genetic Studies of Endocrine Tumours - purchase of a Corbett Research Gel Scan 2000 DNA Fragment A; Marsh D, Robinson B; Rebecca L Cooper Medical Research Foundation/Research Support.
  • A novel regulator of phosphate transport in oncogenic osteomalacia; Mason R, Robinson B; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Expression and regulation of adhesion molecules in rheumatoid synovial endothelium; Schrieber L, To S, Robinson B, Hyland V; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Novel regulators of phosphate homeostasis in phosphate wasting disorders; Mason R, Robinson B, Nelson A; National Health and Medical Research Council (NHMRC)/Project Grants.

1999

  • Use of the cytogenetic technique comparative genomic hybridisation (CGH) for the identification of novel oncogenes and tumor suppressor genes; Marsh D, Robinson B; Clive & Vera Ramaciotti Foundation/Research Grants.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Gild, M., Clifton-Bligh, R., Robinson, B. (2013). Multiple Endocrine Neoplasia Type 2 and Bone. In Rajesh V Thakker, Michael P Whyte, John A Eisman, Takashi Igarashi (Eds.), Genetics of Bone Biology and Skeletal Disease, (pp. 505-513). London, United Kingdom: Academic Press Elsevier.
  • Learoyd, D., Robinson, B., Tacon, L. (2010). Medullary Thyroid Carcinoma and Multiple Endocrine Neoplasia Type 2. In J Larry Jameson and Leslie J De Groot (Eds.), Endocrinology 6th Edition, (pp. 90-91). United States: Elsevier Inc.

Journals

  • Zearo, S., Kim, E., Zhu, Y., Zhao, J., Sidhu, S., Robinson, B., Soon, P. (2014). MicroRNA-484 is more highly expressed in serum of early breast cancer patients compared to healthy volunteers. BMC Cancer, 14(1), 1-7. [More Information]
  • Gundara, J., Zhao, J., Gill, A., Clifton-Bligh, R., Robinson, B., Delbridge, L., Sidhu, S. (2014). Nodal metastasis microRNA expression correlates with the primary tumour in MTC. ANZ Journal of Surgery, 84(4), 235-239. [More Information]
  • Gill, A., Toon, C., Clarkson, A., Sioson, L., Chou, A., Winship, I., Robinson, B., Benn, D., Clifton-Bligh, R., Dwight, T. (2014). Succinate dehydrogenase deficiency is rare in pituitary adenomas. American Journal of Surgical Pathology, 38(4), 560-566. [More Information]
  • Glover, A., Ip, J., Zhao, J., Soon, P., Robinson, B., Sidhu, S. (2013). Current management options for recurrent adrenocortical carcinoma. OncoTargets and Therapy, 6, 635-643. [More Information]
  • Kruijff, S., Aniss, A., Chen, P., Sidhu, S., Delbridge, L., Robinson, B., Clifton-Bligh, R., Roach, P., Gill, A., Learoyd, D., Sywak, M. (2013). Decreasing the dose of radioiodine for remnant ablation does not increase structural recurrence rates in papillary thyroid carcinoma. Surgery, 154(6), 1337-1345. [More Information]
  • Agrawal, N., Jiao, Y., Sausen, M., Leary, R., Bettegowda, C., Roberts, N., Bhan, S., Ho, A., Khan, Z., Bishop, J., Robinson, B., et al (2013). Exomic Sequencing of Medullary Thyroid Cancer Reveals Dominant and Mutually Exclusive Oncogenic Mutations in RET and RAS. Journal of Clinical Endocrinology and Metabolism, 98(2), e364-e369. [More Information]
  • Dwight, T., Mann, K., Benn, D., Robinson, B., McKelvie, P., Gill, A., Winship, I., Clifton-Bligh, R. (2013). Familial SDHA Mutation Associated With Pituitary Adenoma and Pheochromocytoma/Paraganglioma. Journal of Clinical Endocrinology and Metabolism, 98(6), E1103-E1108. [More Information]
  • Dwight, T., Benn, D., Clarkson, A., Vilain, R., Lipton, L., Robinson, B., Clifton-Bligh, R., Gill, A. (2013). Loss of SDHA Expression Identifies SDHA Mutations in Succinate Dehydrogenase–deficient Gastrointestinal Stromal Tumors. The American Journal of Surgical Pathology, 37(2), 226-233. [More Information]
  • McCormack, A., Kaplan, W., Gill, A., Little, N., Cook, R., Robinson, B., Clifton-Bligh, R. (2013). MGMT expression and pituitary tumours: relationship to tumour biology. Pituitary, 16(2), 208-219. [More Information]
  • Lee, J., Zhao, J., Clifton-Bligh, R., Gill, A., Gundara, J., Ip, J., Glover, A., Sywak, M., Delbridge, L., Robinson, B., Sidhu, S. (2013). MicroRNA-222 and MicroRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer. Cancer, 119(24), 4358-4365. [More Information]
  • Versnick, M., Popadich, A., Sidhu, S., Sywak, M., Robinson, B., Delbridge, L. (2013). Minimally invasive parathyroidectomy provides a conservative surgical option for multiple endocrine neoplasia type 1-primary hyperparathyroidism. Surgery, 154(1), 101-105. [More Information]
  • Wells, S., Pacini, F., Robinson, B., Santoro, M. (2013). Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: An update. Journal of Clinical Endocrinology and Metabolism, 98(8), 3149-3164. [More Information]
  • Ghayee, H., Bhagwandin, V., Stastny, V., Click, A., Ding, L., Mizrachi, D., Zou, Y., Chari, R., Lam, W., Bachoo, R., Sidhu, S., Robinson, B., et al (2013). Progenitor cell line (hPheo1) derived from a human pheochromocytoma tumor. PLoS One, 8(6), 1-8. [More Information]
  • Pozo, K., Castro-Rivera, E., Tan, C., Plattner, F., Schwach, G., Siegl, V., Meyer, D., Guo, A., Gundara, J., Mettlach, G., Sidhu, S., Robinson, B., et al (2013). The Role of Cdk5 in Neuroendocrine Thyroid Cancer. Cancer Cell, 24(4), 499-511. [More Information]
  • Bullock, M., Duncan, E., O'Neill, C., Tacon, L., Sywak, M., Sidhu, S., Delbridge, L., Learoyd, D., Robinson, B., Ludgate, M., Clifton-Bligh, R. (2012). Association of FOXE1 Polyalanine Repeat Region with Papillary Thyroid Cancer. Journal of Clinical Endocrinology and Metabolism, 97(9), e1814-e1819. [More Information]
  • Akerstrom, T., Crona, J., Verdugo, A., Starker, L., Cupisti, K., Willenberg, H., Knoefel, W., Saeger, W., Feller, A., Ip, J., Soon, P., Robinson, B., Sidhu, S., et al (2012). Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter. PLoS One, 7(7), 1-7. [More Information]
  • Finfer, S., Liu, B., Chittock, D., Norton, R., Myburgh, J., McArthur, C., Mitchell, I., Foster, D., Dhingra, V., Henderson, W., Robinson, B., et al (2012). Hypoglycemia and Risk of Death in Critically Ill Patients. The New England Journal of Medicine, 367(12), 1108-1118. [More Information]
  • Goulston, K., Oates, R., Shinfield, S., Robinson, B. (2012). Medical student education: what it costs and how it is funded. Internal Medicine Journal, 42(10), 1149-1152. [More Information]
  • Prichard, R., Lee, J., Gill, A., Sywak, M., Fingleton, L., Robinson, B., Sidhu, S., Delbridge, L. (2012). Mucoepidermoid carcinoma of the thyroid: a report of three cases and postulated histogenesis. Thyroid, 22(2), 205-209. [More Information]
  • Gundara, J., Zhao, J., Robinson, B., Sidhu, S. (2012). Oncophagy: harnessing regulation of autophagy in cancer therapy. Endocrine-Related Cancer, 19(6), R281-R295. [More Information]
  • Lee, J., Zhao, J., Clifton-Bligh, R., Gill, A., Gundara, J., Ip, J., Sywak, M., Delbridge, L., Robinson, B., Sidhu, S. (2012). Papillary Thyroid Carcinoma in Pregnancy: A Variant of the Disease? Annals of Surgical Oncology, 19(13), 4210-4216. [More Information]
  • Pacini, F., Ito, Y., Luster, M., Pitoia, F., Robinson, B., Wirth, L. (2012). Radioactive iodine-refractory differentiated thyroid cancer: Unmet needs and future directions. Expert Review of Endocrinology and Metabolism, 7(5), 541-544. [More Information]
  • Bullock, M., O'Neil, C., Chou, A., Clarkson, A., Dodds, T., Toon, C., Sywak, M., Sidhu, S., Delbridge, L., Robinson, B., Learoyd, D., Clifton-Bligh, R., Gill, A., et al (2012). Utilization of a MAB for BRAFV600E detection in papillary thyroid carcinoma. Endocrine-Related Cancer, 19(6), 779-784. [More Information]
  • Wells, J., Robinson, B., Gagel, R., Dralle, H., Fagin, J., Santoro, M., Baudin, E., Elisei, R., Jarzab, B., Vasselli, J., et al (2012). Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial. Journal of Clinical Oncology, 30(2), 134-141. [More Information]
  • Tacon, L., Prichard, R., Soon, P., Robinson, B., Clifton-Bligh, R., Sidhu, S. (2011). Current and Emerging Therapies for Advanced Adrenocortical Carcinoma. The Oncologist, 16(1), 36-48. [More Information]
  • Gundara, J., Robinson, B., Sidhu, S. (2011). Evolution of the "autophagamiR". Autophagy, 7(12), 1553-1554. [More Information]
  • Abraham, D., Low, T., Messina, M., Jackson, N., Gill, A., Chou, A., Delbridge, L., Learoyd, D., Robinson, B., Sidhu, S., Sywak, M. (2011). Medullary Thyroid Carcinoma: Long-Term Outcomes of Surgical Treatment. Annals of Surgical Oncology, 18, 219-225. [More Information]
  • Abraham, D., Jackson, N., Gundara, J., Zhao, J., Gill, A., Delbridge, L., Robinson, B., Sidhu, S. (2011). MicroRNA Profiling of Sporadic and Hereditary Medullary Thyroid Cancer Identifies Predictors of Nodal Metastasis, Prognosis, and Potential Therapeutic Targets. Clinical Cancer Research, 17(14), 4772-4781. [More Information]
  • Fowler, A., Thomson, D., Giles, K., Maleki, S., Mreich, E., Wheeler, H., Leedman, P., Biggs, M., Cook, R., Little, N., Robinson, B., McDonald, K. (2011). miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion. European Journal of Cancer, 47(6), 953-963. [More Information]
  • Gild, M., Bullock, M., Robinson, B., Clifton-Bligh, R. (2011). Multikinase inhibitors: a new option for the treatment of thyroid cancer. Nature Reviews Endocrinology, 7(10), 617-624. [More Information]
  • Brown, S., O'Neill, C., Suliburk, J., Sidhu, S., Sywak, M., Gill, A., Robinson, B., Delbridge, L. (2011). Parathyroid carcinoma: increasing incidence and changing presentation. ANZ Journal of Surgery, 81(7-8), 528-532. [More Information]
  • Mevawalla, N., McMullen, T., Sidhu, S., Sywak, M., Robinson, B., Delbridge, L. (2011). Presentation of Clinically Solitary Thyroid Nodules in Surgical Patients. Thyroid, 21(1), 55-59. [More Information]
  • Gill, A., Pachter, N., Clarkson, A., Tucker, K., Winship, I., Benn, D., Robinson, B., Clifton-Bligh, R. (2011). Renal tumors and hereditary pheochromocytoma-paraganglioma syndrome type 4. The New England Journal of Medicine, 364(9), 885-886. [More Information]
  • Gill, A., Pachter, N., Chou, A., Young, B., Clarkson, A., Tucker, K., Winship, I., Earls, P., Benn, D., Robinson, B., Clifton-Bligh, R., et al (2011). Renal Tumors Associated With Germline SDHB Mutation Show Distinctive Morphology. American Journal of Surgical Pathology, 35(10), 1578-1585. [More Information]
  • O'Neill, C., Bullock, M., Chou, A., Sidhu, S., Delbridge, L., Robinson, B., Gill, A., Learoyd, D., Clifton-Bligh, R., Sywak, M. (2010). BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer. Surgery, 148(6), 1139-1146. [More Information]
  • Hahn, M., Howell, V., Gill, A., Clarkson, A., Weaire-Buchanan, G., Robinson, B., Delbridge, L., Gimm, O., Schmitt, W., Teh, B., Marsh, D. (2010). CDC73/HRPT2 CpG island hypermethylation and mutation of 5'-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors. Endocrine-Related Cancer, 17(1), 273-282. [More Information]
  • Figtree, G., Guzik, T., Robinson, B., Channon, K., Watkins, H. (2010). Functional estrogen receptor alpha promoter polymorphism is associated with improved endothelial-dependent vasolidation. International Journal of Cardiology, 143(2), 207-208. [More Information]
  • Gill, A., Chou, A., Vilain, R., Clarkson, A., Lui, M., Jin, R., Tobias, V., Samra, J., Goldstein, D., Smith, C., Smith, R., Sywak, M., Sidhu, S., Robinson, B., Eckstein, R., Benn, D., Clifton-Bligh, R., et al (2010). Immunohistochemistry for SDHB Divides Gastrointestinal Stromal Tumors (GISTs) into 2 Distinct Types. American Journal of Surgical Pathology, 34(5), 636-644. [More Information]
  • Gill, A., Benn, D., Chou, A., Clarkson, A., Muljono, A., Meyer-Rochow, G., Richardson, A., Sidhu, S., Robinson, B., Clifton-Bligh, R. (2010). Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes. Human Pathology, 41(6), 805-814. [More Information]
  • Abraham, D., Delbridge, L., Clifton-Bligh, R., Clifton-Bligh, P., Grodski, S., Robinson, B., Messina, M., Sidhu, S. (2010). Medullary thyroid carcinoma presenting with an initial CEA elevation. ANZ Journal of Surgery, 80(11), 831-833. [More Information]
  • Meyer-Rochow, G., Jackson, N., Conaglen, J., Whittle, D., Kunnimalaiyaan, M., Chen, H., Westin, G., Sandgren, J., Stalberg, P., Khanafshar, E., Gill, A., Clifton-Bligh, R., Robinson, B., Benn, D., Sidhu, S., et al (2010). MicroRNA profiling of benign and malignant pheochromocytoma identifies novel diagnostic and therapeutic targets. Endocrine-Related Cancer, 17(3), 835-846. [More Information]
  • Matar, E., Cook, R., Fowler, A., Biggs, M., Little, N., Wheeler, H., Robinson, B., McDonald, K. (2010). Post-contrast enhancement as a clinical indicator of prognosis in patients with anaplastic astrocytoma. Journal of Clinical Neuroscience, 17(8), 993-996. [More Information]
  • Isaacs, J., Mcmullen, T., Sidhu, S., Sywak, M., Robinson, B., Delbridge, L. (2010). Predictive value of the Delphian and level VI nodes in papillary thyroid cancer. ANZ Journal of Surgery, 80(11), 834-838. [More Information]
  • McDonald, K., McDonnell, J., Muntoni, A., Henson, J., Hegi, M., von Deimling, A., Wheeler, H., Cook, R., Biggs, M., Little, N., Robinson, B., Reddel, R., et al (2010). Presence of Alternative Lengthening of Telomeres Mechanism in Patients With Glioblastoma Identifies a Less Aggressive Tumor Type With Longer Survival. Journal of Neuropathology and Experimental Neurology, 69(7), 729-736. [More Information]
  • Meyer-Rochow, G., Schembri, G., Benn, D., Sywak, M., Delbridge, L., Robinson, B., Roach, P., Sidhu, S. (2010). The Utility of Metaiodobenzylguanidine Single Photon Emission Computed Tomography/Computed Tomography (MIBG SPECT/CT) for the Diagnosis of Pheochromocytoma. Annals of Surgical Oncology, 17(2), 392-400. [More Information]
  • Robinson, B., Paz-Ares, L., Krebs, A., Vasselli, J., Haddad, R. (2010). Vandetanib (100 mg) in Patients with Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer. Journal of Clinical Endocrinology and Metabolism, 95(6), 2664-2671. [More Information]
  • Howell, V., Gill, A., Clarkson, A., Nelson, A., Dunne, R., Delbridge, L., Robinson, B., Teh, B., Gimm, O., Marsh, D. (2009). Accuracy of Combined Protein Gene Product 9.5 and Parafibromin Markers for Immunohistochemical Diagnosis of Parathyroid Carcinoma. Journal of Clinical Endocrinology and Metabolism, 94(2), 434-441. [More Information]
  • Neumann, H., Erlic, Z., Boedeker, C., Rybicki, L., Robledo, M., Hermsen, M., Schiavi, F., Falcioni, M., Kwok, P., Benn, D., Robinson, B., Learoyd, D., et al (2009). Clinical Predictors for Germline Mutations in Head and Neck Paraganglioma Patients: Cost Reduction Strategy in Genetic Diagnostic Process as Fall-Out. Cancer Research, 69(8), 3650-3656.
  • Meyer-Rochow, G., Smith, J., Richardson, A., Marsh, D., Sidhu, S., Robinson, B., Benn, D. (2009). Denaturing High Performance Liquid Chromatography Detection of SDHB, SDHD, and VHL Germline Mutations in Pheochromocytoma. Journal of Surgical Research, 157, 55-62. [More Information]
  • Elston, M., Clifton-Bligh, R., Robinson, B. (2009). Familial pituitary tumor syndromes. Nature Reviews Endocrinology, 5(8), 453-61. [More Information]
  • Finfer, S., Chittock, D., Su, S., Blair, D., Foster, D., Dhingra, V., Bellomo, R., Cook, D., Dodek, P., Henderson, W., Heritier, S., Myburgh, J., Norton, R., Robinson, B., et al (2009). Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine, 360(13), 1283-1297. [More Information]
  • Meyer-Rochow, G., McMullen, T., Sywak, M., Robinson, B. (2009). Intra-abdominal insular thyroid carcinoma metastasis. Thyroid, 19(5), 527-530. [More Information]
  • McCormack, A., McDonald, K., Gill, A., Clark, S., Burt, M., Campbell, K., Braund, W., Little, N., Cook, R., Grossman, A., Robinson, B., Clifton-Bligh, R. (2009). Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours. Clinical Endocrinology, 71(2), 226-233. [More Information]
  • Soon, P., Gill, A., Benn, D., Clarkson, A., Robinson, B., McDonald, K., Sidhu, S. (2009). Microarray gene expression and immunohistochemistry analyses of adrenocortical tumours identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas. Endocrine-Related Cancer, 16(2), 573-583. [More Information]
  • Soon, P., Tacon, L., Gill, A., Bambach, C., Sywak, M., Campbell, P., Yeh, M., Wong, S., Clifton-Bligh, R., Robinson, B., Sidhu, S. (2009). miR-195 and miR-483-5p identified as predictors of poor prognosis in adrenocortical cancer. Clinical Cancer Research, 15(24), 7684-7692. [More Information]
  • Elston, M., Gill, A., Conaglen, J., Clarkson, A., Cook, R., Little, N., Robinson, B., Clifton-Bligh, R., McDonald, K. (2009). Nuclear Accumulation of E-Cadherin Correlates with Loss of Cytoplasmic Membrane Staining and Invasion in Pituitary Adenomas. Journal of Clinical Endocrinology and Metabolism, 94(4), 1436-1442. [More Information]
  • Meyer-Rochow, G., Soon, P., Delbridge, L., Sywak, M., Bambach, C., Clifton-Bligh, R., Robinson, B., Sidhu, S. (2009). Outcomes of minimally invasive surgery for phaeochromocytoma. ANZ Journal of Surgery, 79(5), 367-370. [More Information]
  • Figtree, G., Robinson, B., Channon, K., Watkins, H. (2009). Polymorphism upstream of estrogen receptor alpha reverses negative regulation of transcription. International Journal of Cardiology, 144(1), 86-8. [More Information]
  • Warusavitarne, J., McDougall, F., de Silva, K., Barnetson, R., Messina, M., Robinson, B., Schnitzler, M. (2009). Restoring TGF-{beta} function in microsatellite unstable (MSI-H) colorectal cancer reduces tumourigenicity but increases metastasis formation. International Journal of Colorectal Disease: clinical and molecular gastroenterology and surgery, 24(2), 139-144. [More Information]
  • Tacon, L., Soon, P., Gill, A., Chou, A., Clarkson, A., Botling, J., Stalberg, P., Skogseid, B., Robinson, B., Sidhu, S., Clifton-Bligh, R. (2009). The glucocorticoid receptor is overexpressed in malignant adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism, 94(11), 4591-4599. [More Information]
  • Figtree, G., Grieve, S., Speller, B., Geiger, M., Robinson, B., Channon, K., Ragoussis, J., Collins, P., Watkins, H. (2008). A commonly occurring polymorphism upstream of the estrogen receptor alpha alters transcription and is associated with increased HDL. Atherosclerosis, 199(2), 354-361. [More Information]
  • Lee, J., Au, A., Foukakis, T., Barbaro, M., Kiss, N., Clifton-Bligh, R., Staaf, J., Borg, A., Delbridge, L., Robinson, B., et al (2008). Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinoma. Endocrine-Related Cancer, 15(3), 801-815. [More Information]
  • Learoyd, D., Robinson, B. (2008). Does genetic screening increase detection of familial medullary thyroid cancer in apparently sporadic cases? - Commentary. Nature clinical practice: Endocrinology and metabolism, 4(3), 132-133. [More Information]
  • Grodski, S., Brown, T., Sidhu, S., Gill, A., Robinson, B., Learoyd, D., Sywak, M., Reeve, T., Delbridge, L. (2008). Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery, 144(6), 1038-1043. [More Information]
  • Soon, P., Yeh, M., Delbridge, L., Bambach, C., Sywak, M., Robinson, B., Sidhu, S. (2008). Laparoscopic surgery is safe for large adrenal lesions. European Journal of Surgical Oncology, 34(1), 67-70. [More Information]
  • Soon, P., Libe, R., Benn, D., Gill, A., Shaw, J., Sywak, M., Groussin, L., Bertagna, X., Gicquel, C., Bertherat, J., McDonald, K., Sidhu, S., Robinson, B. (2008). Loss of Heterozygosity of 17p13, With Possible Involvement of ACADVL and ALOX15B, in the Pathogenesis of Adrenocortical Tumors. Annals of Surgery, 247(1), 157-164. [More Information]
  • Payne, C., Maleki, S., Messina, M., O'Sullivan, M., Stone, G., Hall, N., Parkinson, J., Wheeler, H., Cook, R., Biggs, M., Robinson, B., McDonald, K., et al (2008). Loss of prostaglandin D2 synthase: a key molecular event in the transition of a low-grade astrocytoma to an anaplastic astrocytoma. Molecular Cancer Therapeutics, 7(10), 3420-3428. [More Information]
  • Low, T., Delbridge, L., Sidhu, S., Learoyd, D., Robinson, B., Roach, P., Sywak, M. (2008). Lymph Node Status Influences Follow-Up Thyroglobulin Levels in Papillary Thyroid Cancer. Annals of Surgical Oncology, 15(10), 2827-2832. [More Information]
  • Soon, P., McDonald, K., Robinson, B., Sidhu, S. (2008). Molecular markers and the pathogenesis of adrenocortical cancer. The Oncologist, 13(5), 548-561. [More Information]
  • Grodski, S., Robinson, B., Sidhu, S. (2008). Nonfunctioning parathyroid cancer presenting as a cervical mass. Thyroid, 18(4), 473-474. [More Information]
  • Kim, L., Holland, A., Srinivasan, S., Cowell, C., Benn, D., Robinson, B. (2008). Paediatric bilateral adrenal phaeochromocytomas in association with a novel mutation in the von Hippel Lindau gene. Journal of Paediatrics and Child Health, 44(9), 514-516. [More Information]
  • Addler, J., Meyer-Rochow, G., Chen, H., Benn, D., Robinson, B., Sippel, R., Sidhu, S. (2008). Pheochromocytoma: current approaches and future directions. The Oncologist, 13(7), 779-793. [More Information]
  • Learoyd, D., Robinson, B. (2008). Routine screening for germline RET mutations is recommended for all patients with medullary thyroid cancer. Nature clinical practice. Endocrinology & metabolism, 5(1), 6-7. [More Information]
  • Elston, M., Gill, A., Conaglen, J., Clarkson, A., Shaw, J., Law, A., Cook, R., Little, N., Clifton-Bligh, R., Robinson, B., McDonald, K. (2008). Wnt Pathway Inhibitors Are Strongly Down-Regulated in Pituitary Tumors. Endocrinology, 149(3), 1235-1242. [More Information]
  • Benn, D., Robinson, B. (2007). Editorial: Pheochromocytoma - quo vadis? Nature clinical practice: Endocrinology and metabolism, 3(5), 377.
  • Soon, P., Benn, D., Gill, A., Robinson, B., McDonald, K. (2007). Es07 microarray gene expression analysis of human adrenocortical tumours. ANZ Journal of Surgery, 77(Suppl.1), A22-A22. [More Information]
  • McDonald, K., O'Sullivan, M., Parkinson, J., Shaw, J., Payne, C., Brewer, J., Young, L., Wheeler, H., Reader, D., Cook, R., Little, N., Robinson, B., et al (2007). IQGAP1 and IGFBP2: valuable biomarkers for determining prognosis in glioma patients. Journal of Neuropathology and Experimental Neurology, 66(5), 405-417. [More Information]
  • Benn, D., Robinson, B. (2007). Pheochromocytoma - quo vadis? Nature clinical practice: Endocrinology and metabolism, 3(5), 377-377. [More Information]
  • Grodski, S., Stalberg, P., Robinson, B., Delbridge, L. (2007). Surgery versus Radioiodine Therapy as Definitive Management for Graves' Disease: The Role of Patient Preference. Thyroid, 17(2), 157-160. [More Information]
  • Lundgren, C., Delbridge, L., Learoyd, D., Robinson, B. (2007). Surgical approach to medullary thyroid cancer. Arquivos Brasileiros de Endocrinologia e Metabologia, 51(5), 818-824. [More Information]
  • Messina, M., Robinson, B. (2007). Technology insight: gene therapy and its potential role in the treatment of medullary thyroid carcinoma. Nature clinical practice: Endocrinology and metabolism, 3(3), 290-301. [More Information]
  • Yan, W., Bautovich, G., Learoyd, D., Robinson, B. (2007). Timing of iodine-123 scintigraphy following use of recombinant human thyrotropin in differentiated thyroid carcinoma. Clinical Nuclear Medicine, 32(5), 375-377. [More Information]
  • Parkinson, J., Wheeler, H., Clarkson, A., McKenzie, C., Biggs, M., Little, N., Cook, R., Messina, M., Robinson, B., McDonald, K. (2007). Variation of O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation in serial samples in glioblastoma. Journal of Neuro-Oncology, DOI 10.1007/s11060-007-9486-0, 1-8. [More Information]
  • Warusavitarne, J., Ramanathan, P., Kaufman, A., Robinson, B., Schnitzler, M. (2006). 5-Fluorouracil (5FU) treatment does not influence invasion and metastasis in microsatellite unstable (MSI-H) colorectal cancer. International Journal of Colorectal Disease: clinical and molecular gastroenterology and surgery, 21(7), 625-631. [More Information]
  • Taylor, J., Gough, S., Hunt, P., Brix, T., Chatterjee, K., Connell, J., Franklyn, J., Hegedus, L., Robinson, B., Wiersinga, W., et al (2006). A genome-wide screen in 1119 relative pairs with autoimmune thyroid disease. Journal of Clinical Endocrinology and Metabolism, 91(2), 646-653.
  • Elston, M., Benn, D., Robinson, B., Conaglen, J. (2006). An apparently sporadic paraganglioma with an SDHB gene germline mutation presenting at age 68 years. Internal Medicine Journal, 36, 129-131.
  • Giordano, T., Au, A., Kuick, R., Thomas, D., Rhodes, D., Wilhelm, Jr., K., Vinco, M., Misek, D., Sanders, D., Zhu, Z., Clifton-Bligh, R., Robinson, B., et al (2006). Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocation. Clinical Cancer Research, 12(7), 1983-1993.
  • Stewart, I., Roddie, C., Gill, A., Clarkson, A., Mirams, M., Coyle, L., Ward, C., Clifton-Bligh, P., Robinson, B., Mason, R., Clifton-Bligh, R. (2006). Elevated serum FGF23 concentrations in plasma cell dyscrasias. Bone, 39(2), 369-376. [More Information]
  • Warner, J., Nyholt, D., Busfield, F., Epstein, M., Burgess, J., Stranks, S., Hill, P., Perry-Keene, D., Learoyd, D., Robinson, B., et al (2006). Familial isolated hyperparathyroidism is linked to a 1.7 Mb region on chromosome 2p13.3-14. Journal of Medical Genetics, 43(3), 1-7.
  • Benn, D., Robinson, B. (2006). Genetic basis of phaeochromocytoma and paraganglioma. Best Practice and Research: Clinical Endocrinology and Metabolism, 20(3), 435-450. [More Information]
  • Benn, D., Marsh, D., Robinson, B., Riches, J. (2006). Genetic testing in pheochromocytoma- and paraganglioma-associated syndromes. New York Academy of Sciences. Annals, 1073, 104-111. [More Information]
  • Stalberg, P., Sidhu, S., Sywak, M., Robinson, B., Wilkinson, M., Delbridge, L. (2006). Intraoperative parathyroid hormone measurement during minimally invasive parathyroidectomy: does it "value-add" to decision-making? Journal of the American College of Surgeons, 203(1), 1-6. [More Information]
  • Bolland, M., Benn, D., Croxson, M., McCall, J., Shaw, J., Baillie, T., Robinson, B. (2006). Letter to the Editor: Gastrointestinal stromal tumour in succinate dehydrogenase subunit B mutation-associated familial phaeochromocytoma/paraganglioma. ANZ Journal of Surgery, 76, 763-765.
  • Palazzo, F., Gosnell, J., Savio, R., Reeve, T., Sidhu, S., Sywak, M., Robinson, B., Delbridge, L. (2006). Lymphadenectomy for papillary thyroid cancer: changes in practice over four decades. European Journal of Surgical Oncology, 32(3), 340-344. [More Information]
  • Gosnell, J., Sywak, M., Sidhu, S., Gough, I., Learoyd, D., Robinson, B., Delbridge, L. (2006). New era: prophylactic surgery for patients with multiple endocrine neoplasia-2a. ANZ Journal of Surgery, 76(7), 586-590. [More Information]
  • Figtree, G., Kindmark, A., Lind, L., Grundberg, E., Speller, B., Robinson, B., Channon, K., Watkins, H. (2006). Novel estrogen receptor alpha promoter polymorphism increases ventricular hypertrophic response to hypertension. Journal of Steroid Biochemistry and Molecular Biology, 103(2), 110-118. [More Information]
  • Au, A., McBride, C., Wilhelm, Jr., K., Koenig, R., Speller, B., Cheung, L., Messina, M., Wentworth, J., Tasevski, V., Learoyd, D., Robinson, B., Clifton-Bligh, R. (2006). PAX8-peroxisome proliferator-activated receptor gamma (PPARgamma) disrupts normal PAX8 or PPARgamma transcriptional function and stimulates follicular thyroid cell growth. Endocrinology, 147(1), 367-376. [More Information]
  • Howell, V., Cardinal, J., Richardson, A., Gimm, O., Robinson, B., Marsh, D. (2006). Rapid Mutation Screening for HRPT2 and MEN1 Mutations Associated with Familial and Sporadic Primary Hyperparathyroidism. Journal of molecular diagnostics, 8(5), 559-566. [More Information]
  • Clarke, J., Patel, S., Raymond, R., Andrew, S., Robinson, B., Dressler, G., Brophy, P. (2006). Regulation of c-Ret in the developing kidney is responsive to Pax2 gene dosage. Human Molecular Genetics, 15(23), 3420-3428. [More Information]
  • Foukakis, T., Au, A., Wallin, G., Geli, J., Forsberg, L., Clifton-Bligh, R., Robinson, B., Lui, W., Zedenius, J., Larsson, C. (2006). The Ras effector NORE1A is suppressed in follicular thyroid carcinomas with a PAX8-PPAR gamma fusion. Journal of Clinical Endocrinology and Metabolism, 91(3), 1143-1149. [More Information]
  • Robinson, B., Sundram, F., Kung, A., Lim-Abrahan, M., Bay, N., Chuan, L., Chung, J., Hsu, L., Kamaruddin, N., Cheah, W., et al (2006). Well-differentiated epithelial thyroid cancer management in the Asia Pacific region: A report and clinical practice guideline. Thyroid, 16(5), 461-469.
  • Dahia, P., Ross, K., Wright, M., Hayashida, C., Santagata, S., Barontini, M., Kung, A., Sanso, G., Powers, J., Benn, D., Marsh, D., Robinson, B., et al (2005). A HIF1-alpha Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas. PLoS Genetics, 1(1), 72-80. [More Information]
  • Cardinal, J., Bergman, L., Hayward, N., Sweet, A., Warner, J., Marks, L., Learoyd, D., Dwight, T., Robinson, B., Epstein, M., Smith, M., et al (2005). A report of a national mutation testing service for the MEN1 gene: clinical presentations and implications for mutation testing. Journal of Medical Genetics, 42(1), 69-74. [More Information]
  • Henson, J., Hannay, J., McCarthy, S., Royds, J., Yeager, T., Robinson, R., Wharton, S., Jellinek, D., Arbuckle, S., Yoo, J., Robinson, B., Learoyd, D., Reddel, R., et al (2005). A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. Clinical Cancer Research, 11(1), 217-225. [More Information]
  • Dechairo, B., Zabaneh, D., Collins, J., Brand, O., Dawson, G., Green, A., Mackay, I., Franklyn, J., Connell, J., Wass, J., Robinson, B., et al (2005). Association of the TSHR gene with Graves'' disease: the first disease specific locus. European Journal of Human Genetics, 13(11), 1223-1230.
  • Benn, D., Gimenez-Roqueplo, A., Reilly, J., Bertherat, J., Burgess, J., Byth Wilson, K., Croxson, M., Dahia, P., Elston, M., Gimm, O., Marsh, D., Robinson, B., et al (2005). Clinical presentation and penetrance of Pheochromocytoma/ Paraganglioma syndromes. Journal of Clinical Endocrinology and Metabolism, 91(3), 827-836. [More Information]
  • Learoyd, D., Robinson, B. (2005). Do all patients with RET mutations associated with multiple endocrine neoplasia type 2 require surgery? Nature clinical practice: Endocrinology and metabolism, 1(2), 60-61.
  • Learoyd, D., Gosnell, J., Elston, M., Saurine, T., Richardson, A., Delbridge, L., Conaglen, J., Robinson, B. (2005). Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations. Clinical Endocrinology, 63(6), 636-641. [More Information]
  • Sidhu, S., Martin, E., Gicquel, C., Melki, J., Clark, S., Campbell, P., Magarey, C., Schulte, K., Roher, H., Delbridge, L., Robinson, B. (2005). Mutation and methylation analysis of TP53 in adrenal carcinogenesis. European Journal of Surgical Oncology, 31(5), 549-554. [More Information]
  • Alderazi, Y., Yeh, M., Robinson, B., Benn, D., Sywak, M., Learoyd, D., Delbridge, L., Sidhu, S. (2005). Phaeochromocytoma: current concepts. Medical Journal of Australia, 183(4), 201-204. [More Information]
  • Harding, J., Yeh, M., Robinson, B., Delbridge, L., Sidhu, S. (2005). Potential pitfalls in the diagnosis of phaeochromocytoma. Medical Journal of Australia, 182(12), 637-639. [More Information]
  • Savio, R., Gosnell, J., Palazzo, F., Sywak, M., Agarwal, G., Cowell, C., Shun, A., Robinson, B., Delbridge, L. (2005). The role of a more extensive surgical approach in the initial multimodality management of papillary thyroid cancer in children. Journal of Pediatric Surgery, 40(11), 1696-1700. [More Information]
  • Howell, V., Zori, R., Stalker, H., Williams, C., Jesse, N., Nelson, A., Robinson, B., Marsh, D. (2004). A molecular diagnosis of hyperparathyroidism-Jaw tumor syndrome in an adolescent with recurrent kidney stones. The Journal of Pediatrics, 145(4), 567-567.
  • Yamazaki, M., Straus, F., Messina, M., Robinson, B., Takeda, T., Hashizume, K., DeGroot, L. (2004). Adenovirus-Mediated Tumor-Specific Combined Gene Therapy Using Herpes Simplex Virus Thymidine/Ganciclovir System And Murine Interleukin-12 Induces Effective Antitumor Activity Against Medullary Thyroid Carcinoma. Cancer Gene Therapy, 11(1), 8-15.
  • Sidhu, S., Sywak, M., Robinson, B., Delbridge, L. (2004). Adrenocortical Cancer: Recent Clinical And Molecular Advances. Current Opinion in Oncology, 16(1), 13-18.
  • Mirams, M., Robinson, B., Mason, R., Nelson, A. (2004). Bone As A Source Of Fgf23: Regulation By Phosphate? Bone, 35(5), 1192-1199.
  • Figtree, G., Robinson, B. (2004). Estrogen receptor polymorphisms in common disease: recent developments. Current Opinion in Endocrinology, Diabetes and Obesity, 11(3), 141-146.
  • Figtree, G., Robinson, B. (2004). Estrogen Receptor Polymorphisms In Common Disease:Recent Developments. Current Opinion in Endocrinology, Diabetes and Obesity, 11(3), 141-146.
  • Parker, D., Robinson, B., O'Donnell, B. (2004). External Ophthalmic Findings In Multiple Endocrine Neoplasia Type 2B. Clinical and Experimental Ophthalmology, 32(4), 420-423.
  • Haven, C., Howell, V., Eilers, P., Dunne, R., Takahashi, M., Van Puijenbroek, M., Furge, K., Kievit, J., Tan, M., Fleuren, G., Robinson, B., Delbridge, L., Philips, J., Nelson, A., Marsh, D., et al (2004). Gene Expression Of Parathyroid Tumors: Molecular Subclassification And Identification Of The Potential Malignant Phenotype. Cancer Research, 64(20), 7405-7411.
  • Warner, J., Epstein, M., Sweet, A., Singh, D., Burgess, J., Stranks, S., Hill, P., Perry-Keene, D., Learoyd, D., Robinson, B., et al (2004). Genetic Testing In Familial Isolated Hyperparathyroidism: Unexpected Results And Their Implications. Journal of Medical Genetics, 41(3), 155-160.
  • Villablanca, A., Calender, A., Forsberg, L., Hoog, A., Cheng, J., Petillo, D., Bauters, C., Kahnoski, K., Ebeling, T., Salmela, P., Richardson, A., Delbridge, L., Robinson, B., et al (2004). Germline And De Novo Mutations In The Hrpt2 Tumour Suppressor Gene In Familial Isolated Hyperparathyroidism (Fihp). Journal of Medical Genetics, 41(3), e32 - 1-e32 - 7.
  • Chan, S., Nery, L., McElduff, A., Wilmshurst, E., Fulcher, G., Robinson, B., Stiel, J., Gunton, J., Clifton-Bligh, P. (2004). Intravenous Pamidronate In The Treatment And Prevention Of Osteoporosis. Internal Medicine Journal, 34(4), 162-166.
  • McDonnell, C., Benn, D., Marsh, D., Robinson, B., Zacharin, M. (2004). K40E: A Novel Succinate Dehydrogenase (Sdh)B Mutation Causing Familial Phaeochromocytoma And Paraganglioma. Clinical Endocrinology, 61(4), 510-514.
  • Bernard, M., Sidhu, S., Berger, N., Peix, J., Marsh, D., Robinson, B., Gaston, V., Le Bouc, Y., Gicquel, C. (2003). A case report in favor of a multistep adrenocortical tumorigenesis. Journal of Clinical Endocrinology and Metabolism, 88(3), 998-1001.
  • Sidhu, S., Gicquel, C., Bambach, C., Campbell, P., Magarey, C., Robinson, B., Delbridge, L. (2003). Clinical and molecular aspects of adrenocortical tumourigenesis. ANZ Journal of Surgery, 73(9), 727-738.
  • Cheung, L., Messina, M., Gill, A., Clarkson, A., Learoyd, D., Delbridge, L., Wentworth, J., Philips, J., Clifton-Bligh, R., Robinson, B. (2003). Detection of the PAX8-PPARgamma fusion oncogene in both follicular thyroid carcinomas and adenomas. Journal of Clinical Endocrinology and Metabolism, 88(1), 354-357.
  • Nelson, A., Clifton-Bligh, R., Mirams, M., Gill, A., Au, A., Clarkson, A., Jueppner, H., Ruff, S., Stalley, P., Scolyer, R., Robinson, B., Mason, R., et al (2003). Fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia. Journal of Clinical Endocrinology and Metabolism, 88(9), 4088-4094.
  • Robinson, B. (2003). Gene discovery in endorinology. Current Opinion in Endocrinology, Diabetes and Obesity, 11, 161.
  • Marsh, D., Theodosopoulos, G., Martin-Schulte, K., Richardson, A., Philips, J., Roher, H., Delbridge, L., Robinson, B. (2003). Genome-wide copy number imbalances identified in familial and sproadic medullary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 88(4), 1866-1872.
  • Robinson, B., Freeman, M., Roach, P., Shields, M. (2003). Hiatal hernia in iodine-131 scintigraphy. Clinical Nuclear Medicine, 28(8), 709-710.
  • Howell, V., Haven, C., Kahnoski, K., Khoo, S., Petillo, D., Chen, J., Fleuren, G., Robinson, B., Delbridge, L., Philips, J., Marsh, D., et al (2003). HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. Journal of Medical Genetics, 40(9), 657-663.
  • Benn, D., Croxson, M., Tucker, K., Bambach, C., Richardson, A., Delbridge, L., Pullan, P., Hammond, J., Marsh, D., Robinson, B. (2003). Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporatid phaeochromaocytomas. Oncogene, 22(9), 1358-1364.
  • Sambrook, P., Hughes, D., Nelson, A., Robinson, B., Mason, R. (2003). Osteocyte viability with glucocorticoid treatment: relation to histomorphometry. Annals of the Rheumatic Diseases, 62(12), 1215-1217.
  • Hammett, R., Robinson, B. (2003). Responses to access block in Australia. Medical Journal of Australia, 178(3), 105-107.
  • Barnetson, R., Eckstein, R., Robinson, B., Schnitzler, M. (2003). There is no increase in frequency of somatic mutations in metastases compared with primary colorectal carcinomas wtih microsatellite instability. Genes Chromosomes and Cancer, 38(2), 149-156. [More Information]
  • Cooper, L., Clifton-Bligh, P., Nery, M., Figtree, G., Twigg, S., Hibbert, E., Robinson, B. (2003). Vitamin D supplementation and bone mineral density in early postmenopausal women. American Journal of Clinical Nutrition, 77(5), 1324-1329.
  • Nelson, A., Barden, J., Martin, E., Tasevski, V., Hogan, G., Mason, R., Robinson, B. (2002). Bioactivity of PTH/PTHrP analogs lacking the 1-14 N-terminal domain. Molecular And Cellular Endocrinology, 189(1-2), 37-49.
  • Messina, M., Yu, M., Both, G., Molloy, P., Robinson, B. (2002). Calcitonin-Specific Transcription and Splicing Targets Gene-Directed Enqyme Prodrug Therapy to Medullary Thyroid Carcinoma Cells. Journal of Clinical Endocrinology and Metabolism, 88(3), 1310-1318.
  • Sidhu, S., Bambach, C., Pillinger, S., Reeve, T., Stokes, G., Robinson, B., Delbridge, L. (2002). Changing Pattern of Adrenalectomy at a Tertiary Referral Centre 1970-2000. ANZ Journal of Surgery, 72(7), 463-466.
  • Sidhu, S., Marsh, D., Theodosopoulos, G., Philips, J., Bambach, C., Campbell, P., Magarey, C., Russell, C., Martin-Schulte, K., Roher, H., Delbridge, L., Robinson, B. (2002). Comparative genomic hybridization analysis of adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism, 87(7), 3467-3474.
  • Cheung, L., Messina, M., Gill, A., Clarkson, A., Learoyd, D., Delbridge, L., Wentworth, J., Philips, J., Clifton-Bligh, R., Robinson, B. (2002). Detection of the PAX8-PPARy Fusion Oncogene in Both Follicular Thyroid Carcinomas and Adenomas. Journal of Clinical Endocrinology and Metabolism, 88(1), 354-357.
  • Yamazaki, M., Zhang, R., Straus, F., Messina, M., Robinson, B., Hashizume, K., DeGroot, L. (2002). Effective gene therapy for medullary thyroid carcinoma using recombinant adenovirus inducing tumor-specific expression of interleukin-12. Gene Therapy (Basingstoke), 9(1), 64-74.
  • Dwight, T., Philips, J., Robinson, B., Twigg, S., Kytola, S., Delbridge, L., Teh, B., Marsh, D., Theodosopoulos, G., Nelson, A., et al (2002). Genetic analysis of lithium-associated parathyroid tumors. European Journal of Endocrinology, 146(5), 619-627.
  • Benn, D., Marsh, D., Robinson, B. (2002). Genetics of pheochromocytoma and paraganglioma. Current Opinion in Endocrinology, Diabetes and Obesity, 9(1), 79-86.
  • Carpten, J., Robbins, C., Villablanca, A., Forsberg, L., Presciuttini, S., Bailey-Wilson, J., Simonds, W., Gillanders, E., Kennedy, A., Robinson, B., et al (2002). HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nature Genetics, , 676-680.
  • Sywak, M., Robinson, B., Clifton-Bligh, P., Reeve, T., Barraclough, B., Fick, G., Delbridge, L. (2002). Increase in presentations and procedure rates for hyperparathyroidism in Northern Sydney and New South Wales. Medical Journal of Australia, 177(5), 246-249.
  • Dwight, T., Nelson, A., Theodosopoulos, G., Richardson, A., Learoyd, D., Philips, J., Delbridge, L., Zedenius, J., Teh, B., Larsson, C., Marsh, D., Robinson, B. (2002). Independent Genetic Events Associated with the Development of Multiple Parathyroid Tumors in Patients with Primary Hyperparqathyroidism. The American Journal of Pathology: cellular and molecular biology of disease, 161(4), 1299-1306.
  • Villablanca, A., Wassif, W., Smith, T., Hoog, A., Vierimaa, O., Kassem, M., Dwight, T., Forsberg, L., Du, Q., Learoyd, D., Robinson, B., et al (2002). Involvement of the MEN1 gene locus in familial isolated hyperparathyroidism. European Journal of Endocrinology, 147(3), 313-322.
  • Delbridge, L., Barraclough, B., Robinson, B., Philips, J., Parkyn, R. (2002). Minimally Invasive Follicular Thyroid Carcinoma: Completion Thyroidectomy or Not? ANZ Journal of Surgery, , 844-845.
  • Agarwal, G., Barraclough, B., Robinson, B., Reeve, T., Delbridge, L. (2002). Minimally Invasive Parathyroidectomy using the 'Focused' Lateral Approach. 1. Results of the First 100 Consecutive Cases. ANZ Journal of Surgery, 72(2), 100-104.
  • Nelson, A., Robinson, B., Marsh, D., Dwight, T., Teh, B., Larsson, C. (2002). Parathyroid tumorigenesis in association with primary hyperparathyroidism. Current Opinion in Endocrinology, Diabetes and Obesity, , 51-60.
  • Barakate, M., Agarwal, G., Reeves, T., Barraclough, B., Robinson, B., Delbridge, L. (2002). Total Thyroidectomy is now the preferred option for the Surgical Management of Graves' Disease. ANZ Journal of Surgery, 72(5), 321-324.
  • Andrew, S., Capes-Davis, A., Delhanty, P., Marsh, D., Mulligan, L., Robinson, B. (2002). Transcriptional repression of the RET proto-oncogene by a mitogen activated protein kinase-dependent signalling pathway. Gene, 298(1), 9-19.
  • Robinson, B., Delbridge, L., Sutherland, A. (2001). Anaesthesia for amiodarone-induced thyrotoxicosis: a case review. Anaesthesia and Intensive Care, 29, 24-29.
  • Nelson, A., Mason, R., Robinson, B., Hogan, E., Martin, E., Ablstrom, H., Astrom, G., Larsson, T., Wibell, L., Ljunggren,, O., et al (2001). Diagnosis of a patient with oncogenic osteomalacia using a phophate uptake bioassay of serum and magnetic resonance imaging. European Journal of Endocrinology, 145, 469-476.
  • Learoyd, D., Messina, M., Robinson, B., Kjellman,, P., Weber, G., Hoog,, A., Wallin, G., Larsson, C., Zedenius, J. (2001). Expression of the RET proto-oncogene in papullary thyroid carcinoma and its correlation with clinical outcome. British Journal of Surgery, 88, 557-563.
  • Messina, M., Learoyd, D., Robinson, B., Both, G., Molloy, P. (2001). Gene therapy for endocrine tumors: strategies and progress. Current Opinion in Endocrinology, Diabetes and Obesity, 8, 35-40.
  • Delbridge, L., Robinson, B., Gauger,, P., Agarwal, G., England,, B., Matz,, K., Wilkinson, M., Thompson, N. (2001). Intraoperative parathyroid hormone monitoring fails to detect double parathyroid adenomas: a 2-institution experience. Surgery, 130, 1005-1010.
  • Barraclough, B., Reeve, T., Delbridge, L., Robinson, B., Barakate, M., Agarwal, G., Wilkinson, M. (2001). Intraoperative quick parathyroid hormone versus same-day parathyroid hormone testing for minimally invasive parathyroidectomy: a cost effectiveness study. Surgery, 130, 963-970.
  • Marsh, D., Robinson, B., Fackenthal, J., Riches, J., Cummings, S., Eng,, C., Olopade, O. (2001). Male breast cancer in Cowden syndrome patients with germline PTEN mutations. Journal of Medical Genetics, 38, 159-164.
  • Nelson, A., Robinson, B., Mason, R., Marsh, D., Holm,, I., Cowell, C., Carpenter, T. (2001). Mutational analysis and genotype-phenotype correlation of the PHEX gene in X-Linked hypophosphphatiemic rickets. Journal of Clinical Endocrinology and Metabolism, 86(8), 3889-3899.
  • Sambrook, P., Hunter, D., Naganathan, V., Mason, R., Robinson, B., Raj, A. (2001). Osteoporosis with low dose corticosteroids: contribution of underlying disease effects and discriminatory ability of ultrasound versus bone densitometry. Journal of Rheumatology, 28, 1063-1067.
  • Nelson, A., Robinson, B., Mason, R., Hogan, E., Holm,, I. (2001). Phosphate wasting in oncogenic osteomalacia: PHEX Is normal and the tumor-derived factor has unique properties. Bone, 28, 430-439.
  • Marsh, D., Howell, V., Benn, D., Robinson, B., Theodosopoulos, G., Riches, J., Proos, A., Eng,, C. (2001). Rapid mutation scanning of genes associated with familial cancer syndromes using denaturing high-performance liquid chromatography. Neoplasia (Spanish Edition): oncologia multidisciplinaria, 3, 236-244.
  • Gunton, J., McElduff, A., Sulway, M., Stiel, J., Kelso, I., Boyce, S., Fulcher, G., Robinson, B., Clifton-Bligh, P., Wilmshurst, E. (2000). Outcome of pregnancies complicated by pre-gestational diabetes mellitus. American Journal of Obstetrics and Gynecology, 40, 38-43.

Conferences

  • Tsang, V., Parker, N., Cassano, J., Dwight, T., Sue, C., Veivers, D., Robinson, B., Benn, D., Clifton-Bligh, R. (2012). Interaction between hypoxia and mutations in the SDH subunit genes associated with phaeochromocytoma/paragangliomas. 2012 Annual Scientific Meeting of the Endocrine Society of Australia and the Society for Reproductive Biology, Gold Coast, Queensland, Australia.
  • Figtree, G., Watkins, H., Robinson, B., Channon, K. (2006). Novel polymorphism in estrogen receptor alpha reverses negative transcriptional regulation and is associated with improved endothelial-dependent vasodilation. American Heart Association Annual Scientific Sessions 2005, United States: American Heart Association.
  • Stewart, I., Roddie, C., Gill, A., Clarkson, A., Mirams, M., Nelson, A., Coyle, L., Ward, C., Clifton-Bligh, R., Robinson, B., Mason, R. (2005). Elevated serum FGF23 concentrations in plasma cell dyscrasias. 27th Annual Meeting of the American Society for Bone and Mineral Research, United States: American Society for Bone and Mineral Research.
  • Shaw, J., Messina, M., Both, G., Molloy, P., Robinson, B. (2005). Transcription targeted gene therapy for medullary thyroid carcinoma. The Australasian Gene Therapy Society - 4th Society Meeting, United states: John Wiley & Sons.

2014

  • Zearo, S., Kim, E., Zhu, Y., Zhao, J., Sidhu, S., Robinson, B., Soon, P. (2014). MicroRNA-484 is more highly expressed in serum of early breast cancer patients compared to healthy volunteers. BMC Cancer, 14(1), 1-7. [More Information]
  • Gundara, J., Zhao, J., Gill, A., Clifton-Bligh, R., Robinson, B., Delbridge, L., Sidhu, S. (2014). Nodal metastasis microRNA expression correlates with the primary tumour in MTC. ANZ Journal of Surgery, 84(4), 235-239. [More Information]
  • Gill, A., Toon, C., Clarkson, A., Sioson, L., Chou, A., Winship, I., Robinson, B., Benn, D., Clifton-Bligh, R., Dwight, T. (2014). Succinate dehydrogenase deficiency is rare in pituitary adenomas. American Journal of Surgical Pathology, 38(4), 560-566. [More Information]

2013

  • Glover, A., Ip, J., Zhao, J., Soon, P., Robinson, B., Sidhu, S. (2013). Current management options for recurrent adrenocortical carcinoma. OncoTargets and Therapy, 6, 635-643. [More Information]
  • Kruijff, S., Aniss, A., Chen, P., Sidhu, S., Delbridge, L., Robinson, B., Clifton-Bligh, R., Roach, P., Gill, A., Learoyd, D., Sywak, M. (2013). Decreasing the dose of radioiodine for remnant ablation does not increase structural recurrence rates in papillary thyroid carcinoma. Surgery, 154(6), 1337-1345. [More Information]
  • Agrawal, N., Jiao, Y., Sausen, M., Leary, R., Bettegowda, C., Roberts, N., Bhan, S., Ho, A., Khan, Z., Bishop, J., Robinson, B., et al (2013). Exomic Sequencing of Medullary Thyroid Cancer Reveals Dominant and Mutually Exclusive Oncogenic Mutations in RET and RAS. Journal of Clinical Endocrinology and Metabolism, 98(2), e364-e369. [More Information]
  • Dwight, T., Mann, K., Benn, D., Robinson, B., McKelvie, P., Gill, A., Winship, I., Clifton-Bligh, R. (2013). Familial SDHA Mutation Associated With Pituitary Adenoma and Pheochromocytoma/Paraganglioma. Journal of Clinical Endocrinology and Metabolism, 98(6), E1103-E1108. [More Information]
  • Dwight, T., Benn, D., Clarkson, A., Vilain, R., Lipton, L., Robinson, B., Clifton-Bligh, R., Gill, A. (2013). Loss of SDHA Expression Identifies SDHA Mutations in Succinate Dehydrogenase–deficient Gastrointestinal Stromal Tumors. The American Journal of Surgical Pathology, 37(2), 226-233. [More Information]
  • McCormack, A., Kaplan, W., Gill, A., Little, N., Cook, R., Robinson, B., Clifton-Bligh, R. (2013). MGMT expression and pituitary tumours: relationship to tumour biology. Pituitary, 16(2), 208-219. [More Information]
  • Lee, J., Zhao, J., Clifton-Bligh, R., Gill, A., Gundara, J., Ip, J., Glover, A., Sywak, M., Delbridge, L., Robinson, B., Sidhu, S. (2013). MicroRNA-222 and MicroRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer. Cancer, 119(24), 4358-4365. [More Information]
  • Versnick, M., Popadich, A., Sidhu, S., Sywak, M., Robinson, B., Delbridge, L. (2013). Minimally invasive parathyroidectomy provides a conservative surgical option for multiple endocrine neoplasia type 1-primary hyperparathyroidism. Surgery, 154(1), 101-105. [More Information]
  • Gild, M., Clifton-Bligh, R., Robinson, B. (2013). Multiple Endocrine Neoplasia Type 2 and Bone. In Rajesh V Thakker, Michael P Whyte, John A Eisman, Takashi Igarashi (Eds.), Genetics of Bone Biology and Skeletal Disease, (pp. 505-513). London, United Kingdom: Academic Press Elsevier.
  • Wells, S., Pacini, F., Robinson, B., Santoro, M. (2013). Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: An update. Journal of Clinical Endocrinology and Metabolism, 98(8), 3149-3164. [More Information]
  • Ghayee, H., Bhagwandin, V., Stastny, V., Click, A., Ding, L., Mizrachi, D., Zou, Y., Chari, R., Lam, W., Bachoo, R., Sidhu, S., Robinson, B., et al (2013). Progenitor cell line (hPheo1) derived from a human pheochromocytoma tumor. PLoS One, 8(6), 1-8. [More Information]
  • Pozo, K., Castro-Rivera, E., Tan, C., Plattner, F., Schwach, G., Siegl, V., Meyer, D., Guo, A., Gundara, J., Mettlach, G., Sidhu, S., Robinson, B., et al (2013). The Role of Cdk5 in Neuroendocrine Thyroid Cancer. Cancer Cell, 24(4), 499-511. [More Information]

2012

  • Bullock, M., Duncan, E., O'Neill, C., Tacon, L., Sywak, M., Sidhu, S., Delbridge, L., Learoyd, D., Robinson, B., Ludgate, M., Clifton-Bligh, R. (2012). Association of FOXE1 Polyalanine Repeat Region with Papillary Thyroid Cancer. Journal of Clinical Endocrinology and Metabolism, 97(9), e1814-e1819. [More Information]
  • Akerstrom, T., Crona, J., Verdugo, A., Starker, L., Cupisti, K., Willenberg, H., Knoefel, W., Saeger, W., Feller, A., Ip, J., Soon, P., Robinson, B., Sidhu, S., et al (2012). Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter. PLoS One, 7(7), 1-7. [More Information]
  • Finfer, S., Liu, B., Chittock, D., Norton, R., Myburgh, J., McArthur, C., Mitchell, I., Foster, D., Dhingra, V., Henderson, W., Robinson, B., et al (2012). Hypoglycemia and Risk of Death in Critically Ill Patients. The New England Journal of Medicine, 367(12), 1108-1118. [More Information]
  • Tsang, V., Parker, N., Cassano, J., Dwight, T., Sue, C., Veivers, D., Robinson, B., Benn, D., Clifton-Bligh, R. (2012). Interaction between hypoxia and mutations in the SDH subunit genes associated with phaeochromocytoma/paragangliomas. 2012 Annual Scientific Meeting of the Endocrine Society of Australia and the Society for Reproductive Biology, Gold Coast, Queensland, Australia.
  • Goulston, K., Oates, R., Shinfield, S., Robinson, B. (2012). Medical student education: what it costs and how it is funded. Internal Medicine Journal, 42(10), 1149-1152. [More Information]
  • Prichard, R., Lee, J., Gill, A., Sywak, M., Fingleton, L., Robinson, B., Sidhu, S., Delbridge, L. (2012). Mucoepidermoid carcinoma of the thyroid: a report of three cases and postulated histogenesis. Thyroid, 22(2), 205-209. [More Information]
  • Gundara, J., Zhao, J., Robinson, B., Sidhu, S. (2012). Oncophagy: harnessing regulation of autophagy in cancer therapy. Endocrine-Related Cancer, 19(6), R281-R295. [More Information]
  • Lee, J., Zhao, J., Clifton-Bligh, R., Gill, A., Gundara, J., Ip, J., Sywak, M., Delbridge, L., Robinson, B., Sidhu, S. (2012). Papillary Thyroid Carcinoma in Pregnancy: A Variant of the Disease? Annals of Surgical Oncology, 19(13), 4210-4216. [More Information]
  • Pacini, F., Ito, Y., Luster, M., Pitoia, F., Robinson, B., Wirth, L. (2012). Radioactive iodine-refractory differentiated thyroid cancer: Unmet needs and future directions. Expert Review of Endocrinology and Metabolism, 7(5), 541-544. [More Information]
  • Bullock, M., O'Neil, C., Chou, A., Clarkson, A., Dodds, T., Toon, C., Sywak, M., Sidhu, S., Delbridge, L., Robinson, B., Learoyd, D., Clifton-Bligh, R., Gill, A., et al (2012). Utilization of a MAB for BRAFV600E detection in papillary thyroid carcinoma. Endocrine-Related Cancer, 19(6), 779-784. [More Information]
  • Wells, J., Robinson, B., Gagel, R., Dralle, H., Fagin, J., Santoro, M., Baudin, E., Elisei, R., Jarzab, B., Vasselli, J., et al (2012). Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial. Journal of Clinical Oncology, 30(2), 134-141. [More Information]

2011

  • Tacon, L., Prichard, R., Soon, P., Robinson, B., Clifton-Bligh, R., Sidhu, S. (2011). Current and Emerging Therapies for Advanced Adrenocortical Carcinoma. The Oncologist, 16(1), 36-48. [More Information]
  • Gundara, J., Robinson, B., Sidhu, S. (2011). Evolution of the "autophagamiR". Autophagy, 7(12), 1553-1554. [More Information]
  • Abraham, D., Low, T., Messina, M., Jackson, N., Gill, A., Chou, A., Delbridge, L., Learoyd, D., Robinson, B., Sidhu, S., Sywak, M. (2011). Medullary Thyroid Carcinoma: Long-Term Outcomes of Surgical Treatment. Annals of Surgical Oncology, 18, 219-225. [More Information]
  • Abraham, D., Jackson, N., Gundara, J., Zhao, J., Gill, A., Delbridge, L., Robinson, B., Sidhu, S. (2011). MicroRNA Profiling of Sporadic and Hereditary Medullary Thyroid Cancer Identifies Predictors of Nodal Metastasis, Prognosis, and Potential Therapeutic Targets. Clinical Cancer Research, 17(14), 4772-4781. [More Information]
  • Fowler, A., Thomson, D., Giles, K., Maleki, S., Mreich, E., Wheeler, H., Leedman, P., Biggs, M., Cook, R., Little, N., Robinson, B., McDonald, K. (2011). miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion. European Journal of Cancer, 47(6), 953-963. [More Information]
  • Gild, M., Bullock, M., Robinson, B., Clifton-Bligh, R. (2011). Multikinase inhibitors: a new option for the treatment of thyroid cancer. Nature Reviews Endocrinology, 7(10), 617-624. [More Information]
  • Brown, S., O'Neill, C., Suliburk, J., Sidhu, S., Sywak, M., Gill, A., Robinson, B., Delbridge, L. (2011). Parathyroid carcinoma: increasing incidence and changing presentation. ANZ Journal of Surgery, 81(7-8), 528-532. [More Information]
  • Mevawalla, N., McMullen, T., Sidhu, S., Sywak, M., Robinson, B., Delbridge, L. (2011). Presentation of Clinically Solitary Thyroid Nodules in Surgical Patients. Thyroid, 21(1), 55-59. [More Information]
  • Gill, A., Pachter, N., Clarkson, A., Tucker, K., Winship, I., Benn, D., Robinson, B., Clifton-Bligh, R. (2011). Renal tumors and hereditary pheochromocytoma-paraganglioma syndrome type 4. The New England Journal of Medicine, 364(9), 885-886. [More Information]
  • Gill, A., Pachter, N., Chou, A., Young, B., Clarkson, A., Tucker, K., Winship, I., Earls, P., Benn, D., Robinson, B., Clifton-Bligh, R., et al (2011). Renal Tumors Associated With Germline SDHB Mutation Show Distinctive Morphology. American Journal of Surgical Pathology, 35(10), 1578-1585. [More Information]

2010

  • O'Neill, C., Bullock, M., Chou, A., Sidhu, S., Delbridge, L., Robinson, B., Gill, A., Learoyd, D., Clifton-Bligh, R., Sywak, M. (2010). BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer. Surgery, 148(6), 1139-1146. [More Information]
  • Hahn, M., Howell, V., Gill, A., Clarkson, A., Weaire-Buchanan, G., Robinson, B., Delbridge, L., Gimm, O., Schmitt, W., Teh, B., Marsh, D. (2010). CDC73/HRPT2 CpG island hypermethylation and mutation of 5'-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors. Endocrine-Related Cancer, 17(1), 273-282. [More Information]
  • Figtree, G., Guzik, T., Robinson, B., Channon, K., Watkins, H. (2010). Functional estrogen receptor alpha promoter polymorphism is associated with improved endothelial-dependent vasolidation. International Journal of Cardiology, 143(2), 207-208. [More Information]
  • Gill, A., Chou, A., Vilain, R., Clarkson, A., Lui, M., Jin, R., Tobias, V., Samra, J., Goldstein, D., Smith, C., Smith, R., Sywak, M., Sidhu, S., Robinson, B., Eckstein, R., Benn, D., Clifton-Bligh, R., et al (2010). Immunohistochemistry for SDHB Divides Gastrointestinal Stromal Tumors (GISTs) into 2 Distinct Types. American Journal of Surgical Pathology, 34(5), 636-644. [More Information]
  • Gill, A., Benn, D., Chou, A., Clarkson, A., Muljono, A., Meyer-Rochow, G., Richardson, A., Sidhu, S., Robinson, B., Clifton-Bligh, R. (2010). Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes. Human Pathology, 41(6), 805-814. [More Information]
  • Learoyd, D., Robinson, B., Tacon, L. (2010). Medullary Thyroid Carcinoma and Multiple Endocrine Neoplasia Type 2. In J Larry Jameson and Leslie J De Groot (Eds.), Endocrinology 6th Edition, (pp. 90-91). United States: Elsevier Inc.
  • Abraham, D., Delbridge, L., Clifton-Bligh, R., Clifton-Bligh, P., Grodski, S., Robinson, B., Messina, M., Sidhu, S. (2010). Medullary thyroid carcinoma presenting with an initial CEA elevation. ANZ Journal of Surgery, 80(11), 831-833. [More Information]
  • Meyer-Rochow, G., Jackson, N., Conaglen, J., Whittle, D., Kunnimalaiyaan, M., Chen, H., Westin, G., Sandgren, J., Stalberg, P., Khanafshar, E., Gill, A., Clifton-Bligh, R., Robinson, B., Benn, D., Sidhu, S., et al (2010). MicroRNA profiling of benign and malignant pheochromocytoma identifies novel diagnostic and therapeutic targets. Endocrine-Related Cancer, 17(3), 835-846. [More Information]
  • Matar, E., Cook, R., Fowler, A., Biggs, M., Little, N., Wheeler, H., Robinson, B., McDonald, K. (2010). Post-contrast enhancement as a clinical indicator of prognosis in patients with anaplastic astrocytoma. Journal of Clinical Neuroscience, 17(8), 993-996. [More Information]
  • Isaacs, J., Mcmullen, T., Sidhu, S., Sywak, M., Robinson, B., Delbridge, L. (2010). Predictive value of the Delphian and level VI nodes in papillary thyroid cancer. ANZ Journal of Surgery, 80(11), 834-838. [More Information]
  • McDonald, K., McDonnell, J., Muntoni, A., Henson, J., Hegi, M., von Deimling, A., Wheeler, H., Cook, R., Biggs, M., Little, N., Robinson, B., Reddel, R., et al (2010). Presence of Alternative Lengthening of Telomeres Mechanism in Patients With Glioblastoma Identifies a Less Aggressive Tumor Type With Longer Survival. Journal of Neuropathology and Experimental Neurology, 69(7), 729-736. [More Information]
  • Meyer-Rochow, G., Schembri, G., Benn, D., Sywak, M., Delbridge, L., Robinson, B., Roach, P., Sidhu, S. (2010). The Utility of Metaiodobenzylguanidine Single Photon Emission Computed Tomography/Computed Tomography (MIBG SPECT/CT) for the Diagnosis of Pheochromocytoma. Annals of Surgical Oncology, 17(2), 392-400. [More Information]
  • Robinson, B., Paz-Ares, L., Krebs, A., Vasselli, J., Haddad, R. (2010). Vandetanib (100 mg) in Patients with Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer. Journal of Clinical Endocrinology and Metabolism, 95(6), 2664-2671. [More Information]

2009

  • Howell, V., Gill, A., Clarkson, A., Nelson, A., Dunne, R., Delbridge, L., Robinson, B., Teh, B., Gimm, O., Marsh, D. (2009). Accuracy of Combined Protein Gene Product 9.5 and Parafibromin Markers for Immunohistochemical Diagnosis of Parathyroid Carcinoma. Journal of Clinical Endocrinology and Metabolism, 94(2), 434-441. [More Information]
  • Neumann, H., Erlic, Z., Boedeker, C., Rybicki, L., Robledo, M., Hermsen, M., Schiavi, F., Falcioni, M., Kwok, P., Benn, D., Robinson, B., Learoyd, D., et al (2009). Clinical Predictors for Germline Mutations in Head and Neck Paraganglioma Patients: Cost Reduction Strategy in Genetic Diagnostic Process as Fall-Out. Cancer Research, 69(8), 3650-3656.
  • Meyer-Rochow, G., Smith, J., Richardson, A., Marsh, D., Sidhu, S., Robinson, B., Benn, D. (2009). Denaturing High Performance Liquid Chromatography Detection of SDHB, SDHD, and VHL Germline Mutations in Pheochromocytoma. Journal of Surgical Research, 157, 55-62. [More Information]
  • Elston, M., Clifton-Bligh, R., Robinson, B. (2009). Familial pituitary tumor syndromes. Nature Reviews Endocrinology, 5(8), 453-61. [More Information]
  • Finfer, S., Chittock, D., Su, S., Blair, D., Foster, D., Dhingra, V., Bellomo, R., Cook, D., Dodek, P., Henderson, W., Heritier, S., Myburgh, J., Norton, R., Robinson, B., et al (2009). Intensive versus conventional glucose control in critically ill patients. New England Journal of Medicine, 360(13), 1283-1297. [More Information]
  • Meyer-Rochow, G., McMullen, T., Sywak, M., Robinson, B. (2009). Intra-abdominal insular thyroid carcinoma metastasis. Thyroid, 19(5), 527-530. [More Information]
  • McCormack, A., McDonald, K., Gill, A., Clark, S., Burt, M., Campbell, K., Braund, W., Little, N., Cook, R., Grossman, A., Robinson, B., Clifton-Bligh, R. (2009). Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours. Clinical Endocrinology, 71(2), 226-233. [More Information]
  • Soon, P., Gill, A., Benn, D., Clarkson, A., Robinson, B., McDonald, K., Sidhu, S. (2009). Microarray gene expression and immunohistochemistry analyses of adrenocortical tumours identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas. Endocrine-Related Cancer, 16(2), 573-583. [More Information]
  • Soon, P., Tacon, L., Gill, A., Bambach, C., Sywak, M., Campbell, P., Yeh, M., Wong, S., Clifton-Bligh, R., Robinson, B., Sidhu, S. (2009). miR-195 and miR-483-5p identified as predictors of poor prognosis in adrenocortical cancer. Clinical Cancer Research, 15(24), 7684-7692. [More Information]
  • Elston, M., Gill, A., Conaglen, J., Clarkson, A., Cook, R., Little, N., Robinson, B., Clifton-Bligh, R., McDonald, K. (2009). Nuclear Accumulation of E-Cadherin Correlates with Loss of Cytoplasmic Membrane Staining and Invasion in Pituitary Adenomas. Journal of Clinical Endocrinology and Metabolism, 94(4), 1436-1442. [More Information]
  • Meyer-Rochow, G., Soon, P., Delbridge, L., Sywak, M., Bambach, C., Clifton-Bligh, R., Robinson, B., Sidhu, S. (2009). Outcomes of minimally invasive surgery for phaeochromocytoma. ANZ Journal of Surgery, 79(5), 367-370. [More Information]
  • Figtree, G., Robinson, B., Channon, K., Watkins, H. (2009). Polymorphism upstream of estrogen receptor alpha reverses negative regulation of transcription. International Journal of Cardiology, 144(1), 86-8. [More Information]
  • Warusavitarne, J., McDougall, F., de Silva, K., Barnetson, R., Messina, M., Robinson, B., Schnitzler, M. (2009). Restoring TGF-{beta} function in microsatellite unstable (MSI-H) colorectal cancer reduces tumourigenicity but increases metastasis formation. International Journal of Colorectal Disease: clinical and molecular gastroenterology and surgery, 24(2), 139-144. [More Information]
  • Tacon, L., Soon, P., Gill, A., Chou, A., Clarkson, A., Botling, J., Stalberg, P., Skogseid, B., Robinson, B., Sidhu, S., Clifton-Bligh, R. (2009). The glucocorticoid receptor is overexpressed in malignant adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism, 94(11), 4591-4599. [More Information]

2008

  • Figtree, G., Grieve, S., Speller, B., Geiger, M., Robinson, B., Channon, K., Ragoussis, J., Collins, P., Watkins, H. (2008). A commonly occurring polymorphism upstream of the estrogen receptor alpha alters transcription and is associated with increased HDL. Atherosclerosis, 199(2), 354-361. [More Information]
  • Lee, J., Au, A., Foukakis, T., Barbaro, M., Kiss, N., Clifton-Bligh, R., Staaf, J., Borg, A., Delbridge, L., Robinson, B., et al (2008). Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinoma. Endocrine-Related Cancer, 15(3), 801-815. [More Information]
  • Learoyd, D., Robinson, B. (2008). Does genetic screening increase detection of familial medullary thyroid cancer in apparently sporadic cases? - Commentary. Nature clinical practice: Endocrinology and metabolism, 4(3), 132-133. [More Information]
  • Grodski, S., Brown, T., Sidhu, S., Gill, A., Robinson, B., Learoyd, D., Sywak, M., Reeve, T., Delbridge, L. (2008). Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery, 144(6), 1038-1043. [More Information]
  • Soon, P., Yeh, M., Delbridge, L., Bambach, C., Sywak, M., Robinson, B., Sidhu, S. (2008). Laparoscopic surgery is safe for large adrenal lesions. European Journal of Surgical Oncology, 34(1), 67-70. [More Information]
  • Soon, P., Libe, R., Benn, D., Gill, A., Shaw, J., Sywak, M., Groussin, L., Bertagna, X., Gicquel, C., Bertherat, J., McDonald, K., Sidhu, S., Robinson, B. (2008). Loss of Heterozygosity of 17p13, With Possible Involvement of ACADVL and ALOX15B, in the Pathogenesis of Adrenocortical Tumors. Annals of Surgery, 247(1), 157-164. [More Information]
  • Payne, C., Maleki, S., Messina, M., O'Sullivan, M., Stone, G., Hall, N., Parkinson, J., Wheeler, H., Cook, R., Biggs, M., Robinson, B., McDonald, K., et al (2008). Loss of prostaglandin D2 synthase: a key molecular event in the transition of a low-grade astrocytoma to an anaplastic astrocytoma. Molecular Cancer Therapeutics, 7(10), 3420-3428. [More Information]
  • Low, T., Delbridge, L., Sidhu, S., Learoyd, D., Robinson, B., Roach, P., Sywak, M. (2008). Lymph Node Status Influences Follow-Up Thyroglobulin Levels in Papillary Thyroid Cancer. Annals of Surgical Oncology, 15(10), 2827-2832. [More Information]
  • Soon, P., McDonald, K., Robinson, B., Sidhu, S. (2008). Molecular markers and the pathogenesis of adrenocortical cancer. The Oncologist, 13(5), 548-561. [More Information]
  • Grodski, S., Robinson, B., Sidhu, S. (2008). Nonfunctioning parathyroid cancer presenting as a cervical mass. Thyroid, 18(4), 473-474. [More Information]
  • Kim, L., Holland, A., Srinivasan, S., Cowell, C., Benn, D., Robinson, B. (2008). Paediatric bilateral adrenal phaeochromocytomas in association with a novel mutation in the von Hippel Lindau gene. Journal of Paediatrics and Child Health, 44(9), 514-516. [More Information]
  • Addler, J., Meyer-Rochow, G., Chen, H., Benn, D., Robinson, B., Sippel, R., Sidhu, S. (2008). Pheochromocytoma: current approaches and future directions. The Oncologist, 13(7), 779-793. [More Information]
  • Learoyd, D., Robinson, B. (2008). Routine screening for germline RET mutations is recommended for all patients with medullary thyroid cancer. Nature clinical practice. Endocrinology & metabolism, 5(1), 6-7. [More Information]
  • Elston, M., Gill, A., Conaglen, J., Clarkson, A., Shaw, J., Law, A., Cook, R., Little, N., Clifton-Bligh, R., Robinson, B., McDonald, K. (2008). Wnt Pathway Inhibitors Are Strongly Down-Regulated in Pituitary Tumors. Endocrinology, 149(3), 1235-1242. [More Information]

2007

  • Benn, D., Robinson, B. (2007). Editorial: Pheochromocytoma - quo vadis? Nature clinical practice: Endocrinology and metabolism, 3(5), 377.
  • Soon, P., Benn, D., Gill, A., Robinson, B., McDonald, K. (2007). Es07 microarray gene expression analysis of human adrenocortical tumours. ANZ Journal of Surgery, 77(Suppl.1), A22-A22. [More Information]
  • McDonald, K., O'Sullivan, M., Parkinson, J., Shaw, J., Payne, C., Brewer, J., Young, L., Wheeler, H., Reader, D., Cook, R., Little, N., Robinson, B., et al (2007). IQGAP1 and IGFBP2: valuable biomarkers for determining prognosis in glioma patients. Journal of Neuropathology and Experimental Neurology, 66(5), 405-417. [More Information]
  • Benn, D., Robinson, B. (2007). Pheochromocytoma - quo vadis? Nature clinical practice: Endocrinology and metabolism, 3(5), 377-377. [More Information]
  • Grodski, S., Stalberg, P., Robinson, B., Delbridge, L. (2007). Surgery versus Radioiodine Therapy as Definitive Management for Graves' Disease: The Role of Patient Preference. Thyroid, 17(2), 157-160. [More Information]
  • Lundgren, C., Delbridge, L., Learoyd, D., Robinson, B. (2007). Surgical approach to medullary thyroid cancer. Arquivos Brasileiros de Endocrinologia e Metabologia, 51(5), 818-824. [More Information]
  • Messina, M., Robinson, B. (2007). Technology insight: gene therapy and its potential role in the treatment of medullary thyroid carcinoma. Nature clinical practice: Endocrinology and metabolism, 3(3), 290-301. [More Information]
  • Yan, W., Bautovich, G., Learoyd, D., Robinson, B. (2007). Timing of iodine-123 scintigraphy following use of recombinant human thyrotropin in differentiated thyroid carcinoma. Clinical Nuclear Medicine, 32(5), 375-377. [More Information]
  • Parkinson, J., Wheeler, H., Clarkson, A., McKenzie, C., Biggs, M., Little, N., Cook, R., Messina, M., Robinson, B., McDonald, K. (2007). Variation of O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation in serial samples in glioblastoma. Journal of Neuro-Oncology, DOI 10.1007/s11060-007-9486-0, 1-8. [More Information]

2006

  • Warusavitarne, J., Ramanathan, P., Kaufman, A., Robinson, B., Schnitzler, M. (2006). 5-Fluorouracil (5FU) treatment does not influence invasion and metastasis in microsatellite unstable (MSI-H) colorectal cancer. International Journal of Colorectal Disease: clinical and molecular gastroenterology and surgery, 21(7), 625-631. [More Information]
  • Taylor, J., Gough, S., Hunt, P., Brix, T., Chatterjee, K., Connell, J., Franklyn, J., Hegedus, L., Robinson, B., Wiersinga, W., et al (2006). A genome-wide screen in 1119 relative pairs with autoimmune thyroid disease. Journal of Clinical Endocrinology and Metabolism, 91(2), 646-653.
  • Elston, M., Benn, D., Robinson, B., Conaglen, J. (2006). An apparently sporadic paraganglioma with an SDHB gene germline mutation presenting at age 68 years. Internal Medicine Journal, 36, 129-131.
  • Giordano, T., Au, A., Kuick, R., Thomas, D., Rhodes, D., Wilhelm, Jr., K., Vinco, M., Misek, D., Sanders, D., Zhu, Z., Clifton-Bligh, R., Robinson, B., et al (2006). Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocation. Clinical Cancer Research, 12(7), 1983-1993.
  • Stewart, I., Roddie, C., Gill, A., Clarkson, A., Mirams, M., Coyle, L., Ward, C., Clifton-Bligh, P., Robinson, B., Mason, R., Clifton-Bligh, R. (2006). Elevated serum FGF23 concentrations in plasma cell dyscrasias. Bone, 39(2), 369-376. [More Information]
  • Warner, J., Nyholt, D., Busfield, F., Epstein, M., Burgess, J., Stranks, S., Hill, P., Perry-Keene, D., Learoyd, D., Robinson, B., et al (2006). Familial isolated hyperparathyroidism is linked to a 1.7 Mb region on chromosome 2p13.3-14. Journal of Medical Genetics, 43(3), 1-7.
  • Benn, D., Robinson, B. (2006). Genetic basis of phaeochromocytoma and paraganglioma. Best Practice and Research: Clinical Endocrinology and Metabolism, 20(3), 435-450. [More Information]
  • Benn, D., Marsh, D., Robinson, B., Riches, J. (2006). Genetic testing in pheochromocytoma- and paraganglioma-associated syndromes. New York Academy of Sciences. Annals, 1073, 104-111. [More Information]
  • Stalberg, P., Sidhu, S., Sywak, M., Robinson, B., Wilkinson, M., Delbridge, L. (2006). Intraoperative parathyroid hormone measurement during minimally invasive parathyroidectomy: does it "value-add" to decision-making? Journal of the American College of Surgeons, 203(1), 1-6. [More Information]
  • Bolland, M., Benn, D., Croxson, M., McCall, J., Shaw, J., Baillie, T., Robinson, B. (2006). Letter to the Editor: Gastrointestinal stromal tumour in succinate dehydrogenase subunit B mutation-associated familial phaeochromocytoma/paraganglioma. ANZ Journal of Surgery, 76, 763-765.
  • Palazzo, F., Gosnell, J., Savio, R., Reeve, T., Sidhu, S., Sywak, M., Robinson, B., Delbridge, L. (2006). Lymphadenectomy for papillary thyroid cancer: changes in practice over four decades. European Journal of Surgical Oncology, 32(3), 340-344. [More Information]
  • Gosnell, J., Sywak, M., Sidhu, S., Gough, I., Learoyd, D., Robinson, B., Delbridge, L. (2006). New era: prophylactic surgery for patients with multiple endocrine neoplasia-2a. ANZ Journal of Surgery, 76(7), 586-590. [More Information]
  • Figtree, G., Kindmark, A., Lind, L., Grundberg, E., Speller, B., Robinson, B., Channon, K., Watkins, H. (2006). Novel estrogen receptor alpha promoter polymorphism increases ventricular hypertrophic response to hypertension. Journal of Steroid Biochemistry and Molecular Biology, 103(2), 110-118. [More Information]
  • Figtree, G., Watkins, H., Robinson, B., Channon, K. (2006). Novel polymorphism in estrogen receptor alpha reverses negative transcriptional regulation and is associated with improved endothelial-dependent vasodilation. American Heart Association Annual Scientific Sessions 2005, United States: American Heart Association.
  • Au, A., McBride, C., Wilhelm, Jr., K., Koenig, R., Speller, B., Cheung, L., Messina, M., Wentworth, J., Tasevski, V., Learoyd, D., Robinson, B., Clifton-Bligh, R. (2006). PAX8-peroxisome proliferator-activated receptor gamma (PPARgamma) disrupts normal PAX8 or PPARgamma transcriptional function and stimulates follicular thyroid cell growth. Endocrinology, 147(1), 367-376. [More Information]
  • Howell, V., Cardinal, J., Richardson, A., Gimm, O., Robinson, B., Marsh, D. (2006). Rapid Mutation Screening for HRPT2 and MEN1 Mutations Associated with Familial and Sporadic Primary Hyperparathyroidism. Journal of molecular diagnostics, 8(5), 559-566. [More Information]
  • Clarke, J., Patel, S., Raymond, R., Andrew, S., Robinson, B., Dressler, G., Brophy, P. (2006). Regulation of c-Ret in the developing kidney is responsive to Pax2 gene dosage. Human Molecular Genetics, 15(23), 3420-3428. [More Information]
  • Foukakis, T., Au, A., Wallin, G., Geli, J., Forsberg, L., Clifton-Bligh, R., Robinson, B., Lui, W., Zedenius, J., Larsson, C. (2006). The Ras effector NORE1A is suppressed in follicular thyroid carcinomas with a PAX8-PPAR gamma fusion. Journal of Clinical Endocrinology and Metabolism, 91(3), 1143-1149. [More Information]
  • Robinson, B., Sundram, F., Kung, A., Lim-Abrahan, M., Bay, N., Chuan, L., Chung, J., Hsu, L., Kamaruddin, N., Cheah, W., et al (2006). Well-differentiated epithelial thyroid cancer management in the Asia Pacific region: A report and clinical practice guideline. Thyroid, 16(5), 461-469.

2005

  • Dahia, P., Ross, K., Wright, M., Hayashida, C., Santagata, S., Barontini, M., Kung, A., Sanso, G., Powers, J., Benn, D., Marsh, D., Robinson, B., et al (2005). A HIF1-alpha Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas. PLoS Genetics, 1(1), 72-80. [More Information]
  • Cardinal, J., Bergman, L., Hayward, N., Sweet, A., Warner, J., Marks, L., Learoyd, D., Dwight, T., Robinson, B., Epstein, M., Smith, M., et al (2005). A report of a national mutation testing service for the MEN1 gene: clinical presentations and implications for mutation testing. Journal of Medical Genetics, 42(1), 69-74. [More Information]
  • Henson, J., Hannay, J., McCarthy, S., Royds, J., Yeager, T., Robinson, R., Wharton, S., Jellinek, D., Arbuckle, S., Yoo, J., Robinson, B., Learoyd, D., Reddel, R., et al (2005). A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. Clinical Cancer Research, 11(1), 217-225. [More Information]
  • Dechairo, B., Zabaneh, D., Collins, J., Brand, O., Dawson, G., Green, A., Mackay, I., Franklyn, J., Connell, J., Wass, J., Robinson, B., et al (2005). Association of the TSHR gene with Graves'' disease: the first disease specific locus. European Journal of Human Genetics, 13(11), 1223-1230.
  • Benn, D., Gimenez-Roqueplo, A., Reilly, J., Bertherat, J., Burgess, J., Byth Wilson, K., Croxson, M., Dahia, P., Elston, M., Gimm, O., Marsh, D., Robinson, B., et al (2005). Clinical presentation and penetrance of Pheochromocytoma/ Paraganglioma syndromes. Journal of Clinical Endocrinology and Metabolism, 91(3), 827-836. [More Information]
  • Learoyd, D., Robinson, B. (2005). Do all patients with RET mutations associated with multiple endocrine neoplasia type 2 require surgery? Nature clinical practice: Endocrinology and metabolism, 1(2), 60-61.
  • Stewart, I., Roddie, C., Gill, A., Clarkson, A., Mirams, M., Nelson, A., Coyle, L., Ward, C., Clifton-Bligh, R., Robinson, B., Mason, R. (2005). Elevated serum FGF23 concentrations in plasma cell dyscrasias. 27th Annual Meeting of the American Society for Bone and Mineral Research, United States: American Society for Bone and Mineral Research.
  • Learoyd, D., Gosnell, J., Elston, M., Saurine, T., Richardson, A., Delbridge, L., Conaglen, J., Robinson, B. (2005). Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations. Clinical Endocrinology, 63(6), 636-641. [More Information]
  • Sidhu, S., Martin, E., Gicquel, C., Melki, J., Clark, S., Campbell, P., Magarey, C., Schulte, K., Roher, H., Delbridge, L., Robinson, B. (2005). Mutation and methylation analysis of TP53 in adrenal carcinogenesis. European Journal of Surgical Oncology, 31(5), 549-554. [More Information]
  • Alderazi, Y., Yeh, M., Robinson, B., Benn, D., Sywak, M., Learoyd, D., Delbridge, L., Sidhu, S. (2005). Phaeochromocytoma: current concepts. Medical Journal of Australia, 183(4), 201-204. [More Information]
  • Harding, J., Yeh, M., Robinson, B., Delbridge, L., Sidhu, S. (2005). Potential pitfalls in the diagnosis of phaeochromocytoma. Medical Journal of Australia, 182(12), 637-639. [More Information]
  • Savio, R., Gosnell, J., Palazzo, F., Sywak, M., Agarwal, G., Cowell, C., Shun, A., Robinson, B., Delbridge, L. (2005). The role of a more extensive surgical approach in the initial multimodality management of papillary thyroid cancer in children. Journal of Pediatric Surgery, 40(11), 1696-1700. [More Information]
  • Shaw, J., Messina, M., Both, G., Molloy, P., Robinson, B. (2005). Transcription targeted gene therapy for medullary thyroid carcinoma. The Australasian Gene Therapy Society - 4th Society Meeting, United states: John Wiley & Sons.

2004

  • Howell, V., Zori, R., Stalker, H., Williams, C., Jesse, N., Nelson, A., Robinson, B., Marsh, D. (2004). A molecular diagnosis of hyperparathyroidism-Jaw tumor syndrome in an adolescent with recurrent kidney stones. The Journal of Pediatrics, 145(4), 567-567.
  • Yamazaki, M., Straus, F., Messina, M., Robinson, B., Takeda, T., Hashizume, K., DeGroot, L. (2004). Adenovirus-Mediated Tumor-Specific Combined Gene Therapy Using Herpes Simplex Virus Thymidine/Ganciclovir System And Murine Interleukin-12 Induces Effective Antitumor Activity Against Medullary Thyroid Carcinoma. Cancer Gene Therapy, 11(1), 8-15.
  • Sidhu, S., Sywak, M., Robinson, B., Delbridge, L. (2004). Adrenocortical Cancer: Recent Clinical And Molecular Advances. Current Opinion in Oncology, 16(1), 13-18.
  • Mirams, M., Robinson, B., Mason, R., Nelson, A. (2004). Bone As A Source Of Fgf23: Regulation By Phosphate? Bone, 35(5), 1192-1199.
  • Figtree, G., Robinson, B. (2004). Estrogen receptor polymorphisms in common disease: recent developments. Current Opinion in Endocrinology, Diabetes and Obesity, 11(3), 141-146.
  • Figtree, G., Robinson, B. (2004). Estrogen Receptor Polymorphisms In Common Disease:Recent Developments. Current Opinion in Endocrinology, Diabetes and Obesity, 11(3), 141-146.
  • Parker, D., Robinson, B., O'Donnell, B. (2004). External Ophthalmic Findings In Multiple Endocrine Neoplasia Type 2B. Clinical and Experimental Ophthalmology, 32(4), 420-423.
  • Haven, C., Howell, V., Eilers, P., Dunne, R., Takahashi, M., Van Puijenbroek, M., Furge, K., Kievit, J., Tan, M., Fleuren, G., Robinson, B., Delbridge, L., Philips, J., Nelson, A., Marsh, D., et al (2004). Gene Expression Of Parathyroid Tumors: Molecular Subclassification And Identification Of The Potential Malignant Phenotype. Cancer Research, 64(20), 7405-7411.
  • Warner, J., Epstein, M., Sweet, A., Singh, D., Burgess, J., Stranks, S., Hill, P., Perry-Keene, D., Learoyd, D., Robinson, B., et al (2004). Genetic Testing In Familial Isolated Hyperparathyroidism: Unexpected Results And Their Implications. Journal of Medical Genetics, 41(3), 155-160.
  • Villablanca, A., Calender, A., Forsberg, L., Hoog, A., Cheng, J., Petillo, D., Bauters, C., Kahnoski, K., Ebeling, T., Salmela, P., Richardson, A., Delbridge, L., Robinson, B., et al (2004). Germline And De Novo Mutations In The Hrpt2 Tumour Suppressor Gene In Familial Isolated Hyperparathyroidism (Fihp). Journal of Medical Genetics, 41(3), e32 - 1-e32 - 7.
  • Chan, S., Nery, L., McElduff, A., Wilmshurst, E., Fulcher, G., Robinson, B., Stiel, J., Gunton, J., Clifton-Bligh, P. (2004). Intravenous Pamidronate In The Treatment And Prevention Of Osteoporosis. Internal Medicine Journal, 34(4), 162-166.
  • McDonnell, C., Benn, D., Marsh, D., Robinson, B., Zacharin, M. (2004). K40E: A Novel Succinate Dehydrogenase (Sdh)B Mutation Causing Familial Phaeochromocytoma And Paraganglioma. Clinical Endocrinology, 61(4), 510-514.

2003

  • Bernard, M., Sidhu, S., Berger, N., Peix, J., Marsh, D., Robinson, B., Gaston, V., Le Bouc, Y., Gicquel, C. (2003). A case report in favor of a multistep adrenocortical tumorigenesis. Journal of Clinical Endocrinology and Metabolism, 88(3), 998-1001.
  • Sidhu, S., Gicquel, C., Bambach, C., Campbell, P., Magarey, C., Robinson, B., Delbridge, L. (2003). Clinical and molecular aspects of adrenocortical tumourigenesis. ANZ Journal of Surgery, 73(9), 727-738.
  • Cheung, L., Messina, M., Gill, A., Clarkson, A., Learoyd, D., Delbridge, L., Wentworth, J., Philips, J., Clifton-Bligh, R., Robinson, B. (2003). Detection of the PAX8-PPARgamma fusion oncogene in both follicular thyroid carcinomas and adenomas. Journal of Clinical Endocrinology and Metabolism, 88(1), 354-357.
  • Nelson, A., Clifton-Bligh, R., Mirams, M., Gill, A., Au, A., Clarkson, A., Jueppner, H., Ruff, S., Stalley, P., Scolyer, R., Robinson, B., Mason, R., et al (2003). Fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia. Journal of Clinical Endocrinology and Metabolism, 88(9), 4088-4094.
  • Robinson, B. (2003). Gene discovery in endorinology. Current Opinion in Endocrinology, Diabetes and Obesity, 11, 161.
  • Marsh, D., Theodosopoulos, G., Martin-Schulte, K., Richardson, A., Philips, J., Roher, H., Delbridge, L., Robinson, B. (2003). Genome-wide copy number imbalances identified in familial and sproadic medullary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 88(4), 1866-1872.
  • Robinson, B., Freeman, M., Roach, P., Shields, M. (2003). Hiatal hernia in iodine-131 scintigraphy. Clinical Nuclear Medicine, 28(8), 709-710.
  • Howell, V., Haven, C., Kahnoski, K., Khoo, S., Petillo, D., Chen, J., Fleuren, G., Robinson, B., Delbridge, L., Philips, J., Marsh, D., et al (2003). HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. Journal of Medical Genetics, 40(9), 657-663.
  • Benn, D., Croxson, M., Tucker, K., Bambach, C., Richardson, A., Delbridge, L., Pullan, P., Hammond, J., Marsh, D., Robinson, B. (2003). Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporatid phaeochromaocytomas. Oncogene, 22(9), 1358-1364.
  • Sambrook, P., Hughes, D., Nelson, A., Robinson, B., Mason, R. (2003). Osteocyte viability with glucocorticoid treatment: relation to histomorphometry. Annals of the Rheumatic Diseases, 62(12), 1215-1217.
  • Hammett, R., Robinson, B. (2003). Responses to access block in Australia. Medical Journal of Australia, 178(3), 105-107.
  • Barnetson, R., Eckstein, R., Robinson, B., Schnitzler, M. (2003). There is no increase in frequency of somatic mutations in metastases compared with primary colorectal carcinomas wtih microsatellite instability. Genes Chromosomes and Cancer, 38(2), 149-156. [More Information]
  • Cooper, L., Clifton-Bligh, P., Nery, M., Figtree, G., Twigg, S., Hibbert, E., Robinson, B. (2003). Vitamin D supplementation and bone mineral density in early postmenopausal women. American Journal of Clinical Nutrition, 77(5), 1324-1329.

2002

  • Nelson, A., Barden, J., Martin, E., Tasevski, V., Hogan, G., Mason, R., Robinson, B. (2002). Bioactivity of PTH/PTHrP analogs lacking the 1-14 N-terminal domain. Molecular And Cellular Endocrinology, 189(1-2), 37-49.
  • Messina, M., Yu, M., Both, G., Molloy, P., Robinson, B. (2002). Calcitonin-Specific Transcription and Splicing Targets Gene-Directed Enqyme Prodrug Therapy to Medullary Thyroid Carcinoma Cells. Journal of Clinical Endocrinology and Metabolism, 88(3), 1310-1318.
  • Sidhu, S., Bambach, C., Pillinger, S., Reeve, T., Stokes, G., Robinson, B., Delbridge, L. (2002). Changing Pattern of Adrenalectomy at a Tertiary Referral Centre 1970-2000. ANZ Journal of Surgery, 72(7), 463-466.
  • Sidhu, S., Marsh, D., Theodosopoulos, G., Philips, J., Bambach, C., Campbell, P., Magarey, C., Russell, C., Martin-Schulte, K., Roher, H., Delbridge, L., Robinson, B. (2002). Comparative genomic hybridization analysis of adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism, 87(7), 3467-3474.
  • Cheung, L., Messina, M., Gill, A., Clarkson, A., Learoyd, D., Delbridge, L., Wentworth, J., Philips, J., Clifton-Bligh, R., Robinson, B. (2002). Detection of the PAX8-PPARy Fusion Oncogene in Both Follicular Thyroid Carcinomas and Adenomas. Journal of Clinical Endocrinology and Metabolism, 88(1), 354-357.
  • Yamazaki, M., Zhang, R., Straus, F., Messina, M., Robinson, B., Hashizume, K., DeGroot, L. (2002). Effective gene therapy for medullary thyroid carcinoma using recombinant adenovirus inducing tumor-specific expression of interleukin-12. Gene Therapy (Basingstoke), 9(1), 64-74.
  • Dwight, T., Philips, J., Robinson, B., Twigg, S., Kytola, S., Delbridge, L., Teh, B., Marsh, D., Theodosopoulos, G., Nelson, A., et al (2002). Genetic analysis of lithium-associated parathyroid tumors. European Journal of Endocrinology, 146(5), 619-627.
  • Benn, D., Marsh, D., Robinson, B. (2002). Genetics of pheochromocytoma and paraganglioma. Current Opinion in Endocrinology, Diabetes and Obesity, 9(1), 79-86.
  • Carpten, J., Robbins, C., Villablanca, A., Forsberg, L., Presciuttini, S., Bailey-Wilson, J., Simonds, W., Gillanders, E., Kennedy, A., Robinson, B., et al (2002). HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nature Genetics, , 676-680.
  • Sywak, M., Robinson, B., Clifton-Bligh, P., Reeve, T., Barraclough, B., Fick, G., Delbridge, L. (2002). Increase in presentations and procedure rates for hyperparathyroidism in Northern Sydney and New South Wales. Medical Journal of Australia, 177(5), 246-249.
  • Dwight, T., Nelson, A., Theodosopoulos, G., Richardson, A., Learoyd, D., Philips, J., Delbridge, L., Zedenius, J., Teh, B., Larsson, C., Marsh, D., Robinson, B. (2002). Independent Genetic Events Associated with the Development of Multiple Parathyroid Tumors in Patients with Primary Hyperparqathyroidism. The American Journal of Pathology: cellular and molecular biology of disease, 161(4), 1299-1306.
  • Villablanca, A., Wassif, W., Smith, T., Hoog, A., Vierimaa, O., Kassem, M., Dwight, T., Forsberg, L., Du, Q., Learoyd, D., Robinson, B., et al (2002). Involvement of the MEN1 gene locus in familial isolated hyperparathyroidism. European Journal of Endocrinology, 147(3), 313-322.
  • Delbridge, L., Barraclough, B., Robinson, B., Philips, J., Parkyn, R. (2002). Minimally Invasive Follicular Thyroid Carcinoma: Completion Thyroidectomy or Not? ANZ Journal of Surgery, , 844-845.
  • Agarwal, G., Barraclough, B., Robinson, B., Reeve, T., Delbridge, L. (2002). Minimally Invasive Parathyroidectomy using the 'Focused' Lateral Approach. 1. Results of the First 100 Consecutive Cases. ANZ Journal of Surgery, 72(2), 100-104.
  • Nelson, A., Robinson, B., Marsh, D., Dwight, T., Teh, B., Larsson, C. (2002). Parathyroid tumorigenesis in association with primary hyperparathyroidism. Current Opinion in Endocrinology, Diabetes and Obesity, , 51-60.
  • Barakate, M., Agarwal, G., Reeves, T., Barraclough, B., Robinson, B., Delbridge, L. (2002). Total Thyroidectomy is now the preferred option for the Surgical Management of Graves' Disease. ANZ Journal of Surgery, 72(5), 321-324.
  • Andrew, S., Capes-Davis, A., Delhanty, P., Marsh, D., Mulligan, L., Robinson, B. (2002). Transcriptional repression of the RET proto-oncogene by a mitogen activated protein kinase-dependent signalling pathway. Gene, 298(1), 9-19.

2001

  • Robinson, B., Delbridge, L., Sutherland, A. (2001). Anaesthesia for amiodarone-induced thyrotoxicosis: a case review. Anaesthesia and Intensive Care, 29, 24-29.
  • Nelson, A., Mason, R., Robinson, B., Hogan, E., Martin, E., Ablstrom, H., Astrom, G., Larsson, T., Wibell, L., Ljunggren,, O., et al (2001). Diagnosis of a patient with oncogenic osteomalacia using a phophate uptake bioassay of serum and magnetic resonance imaging. European Journal of Endocrinology, 145, 469-476.
  • Learoyd, D., Messina, M., Robinson, B., Kjellman,, P., Weber, G., Hoog,, A., Wallin, G., Larsson, C., Zedenius, J. (2001). Expression of the RET proto-oncogene in papullary thyroid carcinoma and its correlation with clinical outcome. British Journal of Surgery, 88, 557-563.
  • Messina, M., Learoyd, D., Robinson, B., Both, G., Molloy, P. (2001). Gene therapy for endocrine tumors: strategies and progress. Current Opinion in Endocrinology, Diabetes and Obesity, 8, 35-40.
  • Delbridge, L., Robinson, B., Gauger,, P., Agarwal, G., England,, B., Matz,, K., Wilkinson, M., Thompson, N. (2001). Intraoperative parathyroid hormone monitoring fails to detect double parathyroid adenomas: a 2-institution experience. Surgery, 130, 1005-1010.
  • Barraclough, B., Reeve, T., Delbridge, L., Robinson, B., Barakate, M., Agarwal, G., Wilkinson, M. (2001). Intraoperative quick parathyroid hormone versus same-day parathyroid hormone testing for minimally invasive parathyroidectomy: a cost effectiveness study. Surgery, 130, 963-970.
  • Marsh, D., Robinson, B., Fackenthal, J., Riches, J., Cummings, S., Eng,, C., Olopade, O. (2001). Male breast cancer in Cowden syndrome patients with germline PTEN mutations. Journal of Medical Genetics, 38, 159-164.
  • Nelson, A., Robinson, B., Mason, R., Marsh, D., Holm,, I., Cowell, C., Carpenter, T. (2001). Mutational analysis and genotype-phenotype correlation of the PHEX gene in X-Linked hypophosphphatiemic rickets. Journal of Clinical Endocrinology and Metabolism, 86(8), 3889-3899.
  • Sambrook, P., Hunter, D., Naganathan, V., Mason, R., Robinson, B., Raj, A. (2001). Osteoporosis with low dose corticosteroids: contribution of underlying disease effects and discriminatory ability of ultrasound versus bone densitometry. Journal of Rheumatology, 28, 1063-1067.
  • Nelson, A., Robinson, B., Mason, R., Hogan, E., Holm,, I. (2001). Phosphate wasting in oncogenic osteomalacia: PHEX Is normal and the tumor-derived factor has unique properties. Bone, 28, 430-439.
  • Marsh, D., Howell, V., Benn, D., Robinson, B., Theodosopoulos, G., Riches, J., Proos, A., Eng,, C. (2001). Rapid mutation scanning of genes associated with familial cancer syndromes using denaturing high-performance liquid chromatography. Neoplasia (Spanish Edition): oncologia multidisciplinaria, 3, 236-244.

2000

  • Gunton, J., McElduff, A., Sulway, M., Stiel, J., Kelso, I., Boyce, S., Fulcher, G., Robinson, B., Clifton-Bligh, P., Wilmshurst, E. (2000). Outcome of pregnancies complicated by pre-gestational diabetes mellitus. American Journal of Obstetrics and Gynecology, 40, 38-43.

To update your profile click here. For support on your academic profile contact .